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ABSTRACT
The integral membrane protein sodium potassium adenosine triphosphate (Na-K-ATPase), has
been extensively studied in various animal cell models. Na-K-ATPase is a multifunctional
enzyme which plays a significant role in cellular physiology by regulating electrochemical
potential, cell volume, pH, cytosolic calcium, and many nutrient and electrolyte transport
processes. As such, it has been implicated in the pathogenesis of inflammatory bowel diseases
(IBD) and has been shown to play a vital role in the malabsorption of nutrients and electrolytes.
In this context, a significant amount of research has been done over the last two decades to
understand the mechanisms of alteration of various nutrient absorptive processes in IBD. Though
it has been well acknowledged that Na-K-ATPase plays an essential role in the alteration of
nutrient absorptive mechanisms during inflammation of the intestine, the molecular mechanisms
responsible for the modulation of Na-K-ATPase in IBD was not known.
To study the regulation of Na-K-ATPase, we used an in vitro model (rat intestinal epithelial cell
line, IEC-18 cells) of intestinal epithelial cells that matured from the crypt to villus cells, very
similar to that seen in the mammalian system. During the maturation process, these cells show an
increase in Na-K-ATPase activity to support the absorptive capacity of the villus cells. The
increased activity of Na-K-ATPase was found to be likely due to phosphorylation of the α1
subunit of Na-K-ATPase rather than altered transcription or trafficking of the enzyme.
Numerous inflammatory mediators are produced during IBD; therefore, it is beneficial to
uncover the role of individual inflammatory mediators in regulating transport processes regulated
by Na-K-ATPase. We found that the inflammatory mediator leukotriene D4 (LTD4) stimulates
the activity of Na-K-ATPase through a Ca-activated PKC pathway in crypt-like cells, while

xvii

prostaglandin E2 (PGE2) reduces the activity of Na-K-ATPase through cAMP-activated PKA
pathway in villus-like IEC-18 cells.

xviii

CHAPTER 1: Na-K-ATPase
1.1 GENERAL INTRODUCTION
Over the last 60 years, since the discovery of Na-K-ATPase by Dr. Skou in 1957, the
significance of Na-K-ATPase has increased tremendously (Skou, 1957). The goal of this
introductory section is to provide some basic information on Na-K-ATPase before delving into
its complexity. This membrane-bound protein, which belongs to the large family of P-typeATPases, transports three sodium ions (Na+) out and two potassium ions (K+) into all animal
cells. Since transportation of these ions is against their gradients, the required energy is generated
by catalyzing ATP. Conventionally, Na-K-ATPase is considered as a pumping protein that
primarily maintains electrochemical potential, cell volume, cytosolic pH, and cytosolic Ca2+
level (Jorgensen, Hakansson, & Karlish, 2003; Skou, 1990; Skou & Esmann, 1992).
Additionally, the pumping function also provides the essential gradient to drive secondary
transport processes for transportation of other ions, nutrients, and neurotransmitters across the
plasma membrane (Jorgensen et al., 2003; Skou, 1990; Skou & Esmann, 1992). However, within
the last two decades, it has been demonstrated that in addition to the pumping function, Na-KATPase also has a signaling role regulating various signaling pathways involved in cell
proliferation, cell cycle, fibrosis, and cell adhesion (Contreras, Shoshani, Flores-Maldonado,
Lazaro, & Cereijido, 1999; Nguyen, Wallace, & Blanco, 2007; Shapiro & Tian, 2011). Since NaK-ATPase has been demonstrated as an essential protein involved in cellular physiology, the
abnormal function of Na-K-ATPase results in the pathological states or diseases such as
hyperkalemia, cataracts (Babula, Masarik, Adam, Provaznik, & Kizek, 2013; Delamere &
Tamiya, 2009; Suhail, 2010), hypertension (Lingrel, 2010; Matchkov & Krivoi, 2016; Therien &
Blostein, 2000), and diabetes (Suhail, 2010).
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1.2 STRUCTURE
Na-K-ATPase is a multimeric protein consisting of three different subunits a, b, and g
(Figure 1). There are tissue-specific isoforms of these subunits, and the combination of these
isoforms yields the functional Na-K-ATPase (Jewell, Shamraj, & Lingrel, 1992). Each subunit
has distinct mRNA and is synthesized independently (Geering, 1988).

Figure 1: Schematic representation of Na-K-ATPase subunits in plasma membrane. (Figure
adapted after the permission from Blanco et al. (Blanco & Mercer, 1998b)).
1.2.1. The Alpha (a) Subunit
The mass of the a subunit is ~112 kDa, having binding sites for ions, ATP, and cardiac
glycosides. The a subunit, also known as the catalytic subunit of Na-K-ATPase, cleaves ATP to
generate the energy required for the pumping of ions. This subunit consists of ten transmembrane
a-helical segments and several cytoplasmic loops, in which both the N- and C-termini of the
2

chains reside inside the cytosol (Fambrough et al., 1994). The transmembrane domain is
primarily the site of cation binding, specifically by transmembrane helices M4, M5, M6, and M8.
However, helices M7, M9, and M10 anchor the a subunit to the membrane (Shinoda, Ogawa,
Cornelius, & Toyoshima, 2009). Cytoplasmic regions are primarily known for ATP binding and
are divided into three different domains: the A-actuator domain acts as a piston during the
pumping activity of the Na-K-ATPase while passing through E1 and E2 stages, the Pphosphorylation domain phosphorylates the enzyme, and the N-nucleotide binding domain binds
the nucleotide as well as proteins including Src.
1.2.2. The Beta (b) Subunit
The b subunit by itself does not play a role in pumping of ions but helps newly
synthesized a subunit to fold correctly and integrate into the plasma membrane (Gatto, McLoud,
& Kaplan, 2001; Geering, 2001). Additionally, the b subunit modulates the function of Na-KATPase by changing the cation binding affinity (Laughery, Todd, & Kaplan, 2003). It has also
been reported that this ~55 kDa subunit plays the role in forming cell-cell junctions (Geering,
2008).
Unlike a subunit, this subunit is a highly glycosylated protein, having two to four
glycosylation sites. The number of glycosylation sites is specific to its isoform (Toyoshima,
Kanai, & Cornelius, 2011). It has also been reported that these glycosylation sites regulate a-b
dimer formation. The b subunit consists of three domains: the N-terminal cytoplasmic domain,
one helical transmembrane domain, and the extracellular domain that interacts with the a-subunit
(Toyoshima et al., 2011). Since the b subunit plays a role in stabilization of the a subunit and
cation binding of the holoenzyme, abnormalities (mutation or deletion) of the b subunit have
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created deleterious effects like hearing or sight loss in Drosophila, motor disabilities in mice, and
polycystic kidney disease in humans (Wilson et al., 2000).
1.2.3. FXYD (g) subunit
The FXYD protein family is not required for the Na-K-ATPase function, but there are
numerous pieces of evidence that this subunit plays an active role in the regulation of Na-KATPase (Beguin et al., 1997; Jones, Davies, & Kidder, 1997). This protein subunit is found to
explicitly modulate the kinetics of Na-K-ATPase by regulating the affinity of ions and ATP for
the enzyme (Csupor, Csorba, & Hohmann, 2016; Klodos & Ottolenghi, 1975). The FXYD
subunit also consists of three domains: the cytoplasmic domain that is primarily a
phosphorylation site for different kinases (PKA and PKC), the helical transmembrane domain,
and the N-terminal extracellular domain (Dey, Rahaman, Chakraborti, & Chakraborti, 2013). It
has already been established that the extracellular domain interacts with Na-K-ATPase, thereby
regulating its function. However, it is still unclear how the FXYD proteins change the binding
capacities of Na+ and K+ and affect their kinetic properties.

1.3. ISOFORMS OF Na-K-ATPase SUBUNITS
There are several isoforms of each subunit. To date, there exist four isoforms of the a
subunit, three isoforms of the b subunit, and seven isoforms of FXYD subunit, expressed
differentially in mammals in a tissue-specific manner, as summarized in Table 1.

4

Subunit
Isoform

Tissue

References

a1

(Fowles, Green, & Ouyang, 2004; He et al., 2001; Hundal, Marette, Ramlal, Liu, & Klip, 1993;
Saha et al., 2015; Shyjan, Cena, Klein, & Levenson, 1990; Shyjan & Levenson, 1989; Sun &
Ball, 1992; Sweadner, McGrail, & Khaw, 1992; Thompson & McDonough, 1996; Urayama,
Shutt, & Sweadner, 1989)
(Fowles et al., 2004; He et al., 2001)

a3

Kidney, Lung, Liver,
Heart, Skeletal muscle,
Thymus, Brain, Intestine,
and Pineal gland
Skeletal muscle, Cardio
myocytes and Brain
Brain and pineal gland

a4

Testis / reproductive cells

b1

Kidney, Lung, Liver,
Heart, Skeletal muscle,
Intestine and Brain
Skeletal muscle, Thymus,
Pineal gland and Brain

(Blanco, Sanchez, Melton, Tourtellotte, & Mercer, 2000; Shamraj & Lingrel, 1994; Woo, James,
& Lingrel, 2000)
(He et al., 2001; Hundal et al., 1993; Saha et al., 2015; Shyjan et al., 1990; Shyjan & Levenson,
1989; Sun & Ball, 1992; Sweadner et al., 1992; Thompson & McDonough, 1996; Urayama et al.,
1989; Woo et al., 2000)
(Blanco et al., 2000; Fowles et al., 2004; He et al., 2001; Hundal et al., 1993; Shamraj & Lingrel,
1994; Shyjan et al., 1990; Sun & Ball, 1992; Thompson & McDonough, 1996; Woo et al., 2000)

a2

b2
b3

FXYD1

Lung, Liver, Skeletal
muscle and Testis
Heart and Skeletal muscle

FXYD2
FXYD3
FXYD4
FXYD5

Kidney
Intestine, Stomach
Kidney
Testis, Intestine

FXYD6

Brain

FXYD7

Brain

(Shyjan et al., 1990; Shyjan & Levenson, 1989; Urayama et al., 1989)

(Blanco et al., 2000; Fowles et al., 2004; He et al., 2001; Hundal et al., 1993; Shamraj & Lingrel,
1994; Shyjan et al., 1990; Sun & Ball, 1992; Thompson & McDonough, 1996; Woo et al., 2000)
(Bell et al., 2008; Geering, 2006; Lubarski, Pihakaski-Maunsbach, Karlish, Maunsbach, & Garty,
2005; Sweadner & Rael, 2000)
(Geering, 2006; Jones et al., 2005; Lubarski et al., 2005; Sweadner & Rael, 2000)
(Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000)
(Geering, 2006; Goldschmidt et al., 2004; Lubarski et al., 2005; Sweadner & Rael, 2000)

(Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000)
(Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000)
(Geering, 2006; Lubarski et al., 2005; Sweadner & Rael, 2000)

Table 1: Tissue distribution of Na-K-ATPase subunit isoforms.
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1.4. PUMPING MECHANISM OF Na-K-ATPase
The current understanding of how the pumping mechanism of Na-K-ATPase works is
mostly based on the earlier studies. In the 1960s, Post and Albers postulated the principle
mechanism for the pumping activity of Na-K-ATPase, which has been the framework for
numerous investigations until now (Albers, 1967; Post, Sen, & Rosenthal, 1965). According to
Post and Albers, Na-K-ATPase exists in two conformation states, E1 and E2. These states are
influenced by interaction with Na+, K+, ATP, and other cardiac glycosides, such as Ouabain, and
they lead to the formation of different intermediates, as shown in Figure 2.

Figure 2: Post-Albers’ model for the Na-K-ATPase pump cycle. Figure reproduced from
(Kaplan, 2002).
The pumping mechanism of Na-K-ATPase can be explained in various steps. First, when
the enzyme is in E1 conformation, it binds to 3Na+ and ATP with high affinity in the cytoplasmic
domain of the enzyme, forming E1ATP3Na. Binding of 3Na+ to this orientation leads to the
phosphorylation of the enzyme, which in turn forms E1P-ADP3Na. The occluded ADP is
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detached from the E1 state, and now the binding site of Na reorients itself to the extracellular
side, forming the E2 state (E2P(3Na)). Three Na+ are released extracellularly, leaving the E2 state
with a phosphate (E2P). In the E2P conformation, Na-K-ATPase binds two K+ with high affinity,
forming E2P2K. The K+ binding induces the dephosphorylation of the enzyme by releasing Pi
intracellularly, forming the better binding of two K+. At this state, (E2(2K)) attaches ATP with
low affinity intracellularly and reorients the K+ binding site to the cytoplasmic domain forming
E1ATP2K. The binding of ATP induces E1 conformation and triggers the release of K+ into the
cells. Thus, releasing two K+ into the cells, Na-K-ATPase returns to the same conformation
E1ATP, which is reactivated to pursue the next cycle. Inhibitory molecules such as cardiotonic
steroids (Ouabain) can bind to Na-K-ATPase on its extracellular site (E2P conformation)
irreversibly.
Despite the robust evidence that most of the steps in Post and Albers scheme are crucial
to the Na-K-ATPase pumping activity, there are controversies regarding the sub-steps of the
reaction cycle (Kaplan, 2002) and whether the functional unit of the enzyme is an ab-protomer
or an oligomer (Dey et al., 2010; Repke & Schon, 1973; Vilsen, Andersen, Petersen, &
Jorgensen, 1987).
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1.5. Na-K-ATPase AS A SIGNALING MOLECULE
Any modulation in the Na-K-ATPase activity by extrinsic or intrinsic factors alters the
physiological state of cells. Hence, the inhibition of the Na-K-ATPase activity leads to changes
in intracellular ion homeostasis primarily by increasing intracellular sodium [Na+]i. This buildup
of [Na+]i leads to changes in intracellular pH via Na+/H+ exchanger, and intracellular calcium
[Ca2+]i via Na+/Ca2+ exchanger (Blaustein, 1993). Such alterations in ions’ dynamics in cells
affect the cellular physiology inducing various signaling processes.

Figure 3: Schematic representation of Na-K-ATPase-mediated signaling through protein
interaction. EGFR- Epidermal growth factor receptor, PLC- Phospholipase C; PKC- Protein
kinase. (Figure reproduced from (Cui & Xie, 2017)).
Low doses of ouabain lead to the activation of classical signaling pathways such as ERK
(Extracellular signal-regulated kinases) and Src pathways. It has been reported that Na-KATPase has been linked with Src protein, forming the Na-K-ATPase-Src complex (Abram &
Courtneidge, 2000; Brown & Cooper, 1996). Src, a non-receptor tyrosine kinase, phosphorylates
various tyrosine-mediated downstream signaling pathways. One of the classical pathways
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activated by Src tyrosine kinase is the phosphorylation of epidermal growth factor receptors,
which in turn activates downstream signals such as the activation of the Ras/Raf/MEK/ERK
pathway, and the production of reactive oxygen species (ROS) (Boscher & Nabi, 2012; Wu et
al., 2013; Yuan et al., 2005). These pathways indeed affect the proliferation, differentiation,
migration, and metabolism of cells resulting in various pathophysiological alterations.
Moreover, Na-K-ATPase has also been associated with various other proteins like PI3K
(Phosphoinositide 3-kinase), PLC (Phospholipase C), IP3R (Inositol triphosphate receptor), and
caveolin-1. Interaction of such proteins with Na-K-ATPase creates a series of signal transduction
pathways, which are collectively named as ‘signalosome’ in caveolae (Blanco, Sanchez, &
Mercer, 1995; Jewell & Lingrel, 1991)
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1.6. REGULATION OF Na-K-ATPase
Na-K-ATPase, a regulatable enzyme, is considered to be regulated both short-term and
long-term depending upon the stimulus. Short-term regulation typically involves either
modulation in kinetic properties of the enzyme or alteration in the trafficking of Na-K-ATPase
from the cytoplasm to the plasma membrane (Therien & Blostein, 2000). The long-term
regulation of Na-K-ATPase, on the other hand, generally affects the synthesis and degradation of
Na-K-ATPase (Therien & Blostein, 2000). There is a considerable amount of investigation
indicating that Na-K-ATPase is regulated by various intrinsic and extrinsic factors. Various
extrinsic factors like inflammatory mediators, hormones, neurotransmitters, and cardiotonic
steroids modulate Na-K-ATPase activity. Also, Na-K-ATPase is intrinsically regulated through
phosphorylation and dephosphorylation reactions by kinases and phosphatases respectively,
which are in turn stimulated by extrinsic factors and intracellular second messengers (Aperia,
1995; Bertorello & Katz, 1993).
The phosphorylation-mediated regulation of Na-K-ATPase is primarily carried out by
protein kinase C (PKC), protein kinase A (PKA), and protein tyrosine kinases (PTKs). These
protein kinases directly or indirectly regulate the activity of Na-K-ATPase. The direct regulation
of Na-K-ATPase activity is through phosphorylation of its subunits (a and g), whereas indirect
regulation of Na-K-ATPase involves the signaling of various pathways that affect the
transcription factor associated with regulating gene expression of the Na-K-ATPase.
1.6.1. PKC-mediated Na-K-ATPase regulation
There are contradictory reports suggesting that the activation of PKC results in the
stimulation or inhibition of Na-K-ATPase activity depending upon cell type and experimental
conditions. One study reported that dopamine reduced Na absorption by inhibiting Na-K-ATPase
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activity in proximal tubule cells and the reduction in activity was mediated by PKC (Aperia,
1995; Bertorello & Katz, 1993). According to a different study, the same hormone increased NaK-ATPase activity in pulmonary epithelial cells and the stimulation was also through PKC
(Barnard et al., 1999; Bertorello, Ridge, Chibalin, Katz, & Sznajder, 1999). Additionally, another
study done by Efendiev et al. suggests that the ultimate activity of Na-K-ATPase is PKC
isoform-dependent (Efendiev, Bertorello, & Pedemonte, 1999). Therefore, the effect of PKC on
Na-K-ATPase activity has been suggested to be cell- and tissue-specific.
Studies performed by Pedemonte et al. and Feraille et al. suggest that stimulation of PKC
by PMA (phorbol 12-myristate 13-acetate) stimulated the activity of the Na-K-ATPase (Feraille
et al., 1995; Pedemonte, Pressley, Cinelli, & Lokhandwala, 1997; Pedemonte, Pressley,
Lokhandwala, & Cinelli, 1997). The increase in the activity of Na-K-ATPase was due to the
translocation of Na-K-ATPase to the membrane. Another study by Efendiev et al reported that
mutation in Ser16 (analogous to Ser11-after posttranslational modification) and Ser23 (analogous to
Ser18-after posttranslational modification) of the a subunit was unable to produce the PMAmediated stimulation of Na-K-ATPase, suggesting the N terminus Ser11 and Ser18 are the
phosphorylation sites for PKC (Efendiev et al., 2000). In contrast, dopamine inhibited the Na-KATPase in renal proximal tubule cells and opossum kidney cells. The reduction of enzyme
activity was mediated through PKC phosphorylation of the a subunit at Ser18 causing Na-KATPase at the plasma membrane to translocate into the cytoplasmic compartment (Chibalin,
Katz, Berggren, & Bertorello, 1997; Chibalin et al., 1999; Chibalin, Pedemonte, et al., 1998;
Chibalin, Zierath, Katz, Berggren, & Bertorello, 1998).
On the other hand, various transcription factors also regulate the activity of Na-KATPase. These factors are specific to the subunits and isoforms of Na-K-ATPase (Li &
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Langhans, 2015). One of the studies done by Galuska et al. reported that stimulation of renal
tubular cells with C-peptide increases the activity of Na-K-ATPase. Increase in enzyme activity
was due to increased expression of a1 subunit by activation of transcription factor ZEB through
PKC and MAPK (Microtubule associated protein kinase) pathways (Galuska et al., 2011).
1.6.2. PKA-mediated Na-K-ATPase regulation
Similar to PKC-mediated regulation of Na-K-ATPase, there are also conflicting reports
suggesting that there is inhibition (Bertorello, Aperia, Walaas, Nairn, & Greengard, 1991),
activation (Cornelius & Logvinenko, 1996), or no effect on Na-K-ATPase activity (Cornelius &
Logvinenko, 1996; Feschenko & Sweadner, 1994) by PKA. A possible justification to these
contradictions is phosphorylation of different isoforms of the a subunit by PKA. This
justification was further corroborated by the study conducted in insect cells (Sf-9), where all
isoforms of the a subunit are expressed. In this study, an endogenous activation of PKA in SF-9
cells activates a3b1 isoenzyme but inhibits a1b1 and a2b1 isoenzyme (Blanco, Sanchez, &
Mercer, 1998). Unlike PKC phosphorylation, PKA targets phosphorylation of the serine residue
present in the C terminus of a subunit, specifically Ser943 (Beguin et al., 1994; Feschenko &
Sweadner, 1994; Fisone et al., 1994).
1.6.3. PKG-mediated Na-K-ATPase regulation
Similar to the PKA- and PKC-mediated regulation, protein kinase G (PKG) also regulates
Na-K-ATPase activity in a tissue- and isoform-specific manner. It has been reported that there is
a cyclic guanosine monophosphate (cGMP)-mediated decrease in Na-K-ATPase in the kidney
(McKee, Scavone, & Nathanson, 1994; Scavone, Scanlon, McKee, & Nathanson, 1995). The
reduced enzyme activity is primarily due to decreased expression of the a1 subunit. However, in
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another study, there is a marked increase of Na-K-ATPase in Purkinje neurons, due to increased
expression of Na-K-ATPase a3 subunit (Nathanson, Scavone, Scanlon, & McKee, 1995).
1.6.4. Tyrosine kinase-mediated regulation of Na-K-ATPase
Besides activation of the tyrosine kinase signaling cascade as discussed above, tyrosineprotein kinase (Sarcoma (Src)) also phosphorylates the tyrosine residue at Tyr10 (analogous to
Tyr5-after posttranslational modification) of the a subunit, resulting in an increase in enzyme
activity (Chibalin et al., 1999). Studies on skeletal muscle stimulation by insulin (Chibalin et al.,
2001), and in kidney proximal tubules where dopamine-like receptor are stimulated (Narkar,
Hussain, & Lokhandwala, 2002) have shown increased tyrosine phosphorylation resulting in
increased Na-K-ATPase activity. Other studies have reported that an increased tyrosine
phosphorylation of Na-K-ATPase α1, by inhibiting protein tyrosine phosphatase (PTP) on
human and pig renal cells, reduces the activity of Na-K-ATPase (El-Beialy et al., 2010)
1.6.5. FXYD-mediated regulation of Na-K-ATPase
FXYD is a signal transmembrane protein composed of an extracellular -N terminus and a
cytoplasmic-C terminus (Dey et al., 2013). A specific domain at the N-terminus interacts with
Na-K-ATPase and hence regulates the activity of Na-K-ATPase, whereas the -C terminus
consists of phosphorylation sites (Dey et al., 2013). To date, there are at least 12 different
members of FXYD expressed differentially in a cell- and tissue-specific manner. FXYD family
proteins are expressed in a wide array of tissues including kidney, colon, pancreas, heart, and
skeletal muscle (J. Y. Cheung et al., 2010). Also, due to the presence of phosphorylation sites in
the C-terminus, FXYD proteins are subject to phosphorylation by different protein kinases
(Cornelius & Mahmmoud, 2007; Cortes, Ribeiro, Barrabin, Alves-Ferreira, & Fontes, 2011;
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Mounsey et al., 2000). Moreover, phosphorylation of FXYDs by kinases modulate the activity of
Na-K-ATPase.
1.6.6. Transcriptional regulation of Na-K-ATPase
The Na-K-ATPase expression is modulated by various factors including hormones,
growth factors, lipids, transcription factors, and extracellular stimuli. These factors modulate the
expression by transcriptionally regulating the subunits of Na-K-ATPase. In the current study, the
focus is on the regulation of a1 and b1 subunit.
1.6.6.1. Transcriptional regulation of Na-K-ATPase a1 subunit
ATP1A1 is the gene responsible for transcribing the a1 subunit. It contains a TATA box
(M. M. Shull, Pugh, & Lingrel, 1990), two mineralocorticoid/glucocorticoid response element
(MRE/GRE) sites (Kolla, Robertson, & Litwack, 1999), binding sites for AP-1, AP-2, AP-3 (M.
M. Shull et al., 1990), SP1 and CTF/NF-1 binding site (M. M. Shull et al., 1990). Additionally,
ATF/CRE binding site is also found in the promoter region of ATP1A1 (Kobayashi &
Kawakami, 1995).
Specificity protein (SP) consists of various transcription factors: Sp1, Sp2, Sp3, and Sp4.
Among these SP transcription factors, Sp1, Sp3, and Sp4 had been shown to increase
transcription of the a1 subunit (Johar, Priya, & Wong-Riley, 2012; M. M. Shull et al., 1990).
Another transcription factor is cAMP response element binding protein family (CREB),
Phosphorylation of CREB by cAMP has been shown to increase transcription of the a1 subunit
(Dagenais et al., 2001). Similarly, phosphorylation of activating transcription factor 1 (ATF-1)
also transcriptionally upregulate the a1 subunit (Kobayashi, Shimomura, Hagiwara, &
Kawakami, 1997). The zinc finger E-Box Binding Homeobox 1 (ZEB1/AREB6) also bind to the
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promoter region of ATP1A1 and stimulates the transcription of a1 subunit in a tissue-specific
manner (Watanabe, Kawakami, Hirayama, & Nagano, 1993).
1.6.6.2. Transcriptional regulation of Na-K-ATPase b1 subunit
The b1 subunit is encoded by the gene ATP1B1 and has been widely studied among all
other subunits. The ATP1B1 gene consists various transcription factors binding sites: three
MRE/GRE half-sites (Derfoul, Robertson, Lingrel, Hall, & Litwack, 1998), four E-boxes
(Espineda, Chang, Twiss, Rajasekaran, & Rajasekaran, 2004), one NF-1 (Espineda et al., 2004),
three prostaglandin response elements (PGRE) (Matlhagela, Borsick, Rajkhowa, & Taub, 2005;
Matlhagela & Taub, 2006b), a hypoxia response element (HRE) (Mony, Lee, Harper, Barwe, &
Langhans, 2013), Smad binding domain (SBD) (Mony et al., 2013), three thyroid response
elements (TRE) (Feng, Orlowski, & Lingrel, 1993), three progesterone element (PRE) half sites
(Cochrane et al., 2012), several Sp1 binding sites (Matlhagela et al., 2005; Matlhagela & Taub,
2006b), and a Cebpb binding sites (Deng et al., 2013). Moreover, the TATA box of ATP1B1 also
consist of calcium and serum response elements (Liu & Gick, 1992).
Similar to the a1 subunit, the b1 subunit is also transcriptionally upregulated by Sp1,
Sp3, and Sp4 in murine neurons by binding to their promoter regions (Johar et al., 2012). Cebpb
also increases the b1 subunit in human epithelial cells by binding to the CCAT box (Deng et al.,
2013). Beside transcriptional upregulation of the b1 subunit, it is transcriptionally repressed by
Snail protein by binding to the E-box on the promoter region (Espineda et al., 2004). Another
transcription factor that represses the b1 subunit is hypoxic-inducible factor-1(HIF-1), which
suppress the transcription of the b1 subunit by binding to a HRE (Hypoxia response element)
(Mony et al., 2013).
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CHAPTER 2: THE GASTROINTESTINAL TRACT AND ROLE OF EICOSANOIDS
2.1. THE GASTROINTESTINAL TRACT
Every day the human gastrointestinal (GI) tract processes 8 to 10 liters of fluid which is
taken orally or secreted inside the intestine every day. Because of the robust absorption
mechanism in the GI tract it only eliminates 100 to 200 mL of fluid waste each day (Kiela &
Ghishan, 2016). Along with fluid secretion and absorption, the GI tract also extracts nutrients,
vitamins, and minerals that are ingested as food material, and provides a barrier against harmful
pathogens and toxins (Kiela & Ghishan, 2016). The process of absorption, secretion and defense
mechanism go hand-in-hand in normal homeostatic conditions. The multiplicity of GI activity is
only possible due to the unique tissue, cellular, and molecular architecture of the small and large
intestine (Figure 4), as well as in combination with other regulatory mechanisms. Regulation of
GI activity includes the complex crosstalk between endocrine and paracrine hormones,
neurotransmitters, immunomodulators, and luminal factors (Kumral & Zfass, 2018; Track,
1980).
2.1.1. Intestinal architecture
The structure of the small intestine gives an advantage for proper absorption of nutrients,
electrolytes, and fluids. The cylindrical small intestine consists of special structural features such
as circular folds (plicae circulares), villus-crypt architecture, and microvilli, which amplify the
absorption process by increasing the surface area about 600-fold (Hilton, 1902; Walton,
Mishkind, Riddle, Tabin, & Gumucio, 2018). However, the large intestine, which generally lacks
these structural features, is only efficient to reabsorb fluid and some fatty acids.
The small intestine has the ability to multitask, for which it needs a variety of cells,
including enterocytes (nutrient absorption), goblet cells (mucus secretion), Paneth cells (defensin

16

production against antimicrobial agents) and enteroendocrine cells (Barker & Clevers, 2010). All
these cell lineages are derived from the stem cells which lie in the pit known as the crypt. Stem
cells divide into rapidly proliferating transit-amplifying cells, which subsequently arise from the
crypt and start to differentiate and begin to express differentiation markers for three lineages:
enterocytes, enteroendocrine and goblet cells (Barker & Clevers, 2010). These cells are fully
differentiated as they reach the crypt-villus junction. These cells move along the crypt-villus axis
as they grow and mature and eventually undergo apoptosis and slough off from the tip of the
villus (Barker, van de Wetering, & Clevers, 2008; van der Flier & Clevers, 2009). The whole
process from the origin of the cell to its death takes about 3 to 5 days (Tesori, Puglisi, Lattanzi,
Gasbarrini, & Gasbarrini, 2013).

Figure 4: Schematic diagram of small intestine architect including crypt and villus cells.
Some stem cells differentiate into Paneth cells that migrate to the bottom of the crypts.
However, the intestinal lining mostly consists of enterocytes that help to absorb nutrients from
the lumen. These enterocytes, while growing from immature crypt cells to fully mature
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absorptive villus cells, have various morphological and physiological alterations. Therefore,
depending on the position of enterocytes along the crypt-villus axis, there is a differential
expression of transport proteins. Most of the transporters (Na-nutrient, NHE3 (Na-hydrogen
exchanger) and SLC26A6) are accrued while moving towards the villus, whereas transporters
like CFTR (Cystic fibrosis transmembrane conductance regulator) exhibit a greater density in the
base of the crypt. However, some of the transporters are expressed equally throughout the cryptvillus axis (Field, 2003; S. K. Singh, Binder, Boron, & Geibel, 1995).
2.1.2. Epithelial cell model
The monolayer of enterocytes in the small intestine provides a semipermeable barrier and
separates two distinct compartments, outer mucosal (lumen) and inner serosal (blood-side)
(Schneeberger, Roth, Nieuwenhuis, & Middendorp, 2018). All enterocytes from the small
intestine to the colon (colonocytes) share a common topography. Enterocytes are polarized
epithelial cells with morphologically and molecularly distinct apical (brush border or luminal)
and basolateral (serosal) membranes (Figure 5). Enterocytes are adhered together from the lateral
side by junctional proteins (such as tight junctions,
adheren junctions, and desmosomes proteins) (Anderson
& Van Itallie, 1995; Giepmans, 2004; Marchiando,
Graham, & Turner, 2010). Tight junction permeability is
relatively leaky towards the small intestine, whereas very
tight towards the colon (Field, 2003).

Figure 5: Typical small intestine epithelial cell.

18

Enterocytes acquire distinct polarized characteristics specifically by inserting transporters
into the brush border or basolateral membrane. Intracellular trafficking processes, cytoskeletal
and protein-sorting signals interact synergistically to direct de novo proteins to either the brush
border or basolateral membrane (Apodaca, 2001; Massey-Harroche, 2000). Generally,
glycosylphosphatidylinositol (GPI) anchors (e.g., alkaline phosphatase) are associated with lipid
rafts, and the GPI anchor targets newly synthesized proteins to the apical membrane (Alberts,
Johnson, & Lewis, 2007). Specific membrane-sorting signals (amino acid sequences) in the
cytoplasmic tail direct proteins to the basolateral membrane. Proteins lacking the membrane
sorting signal and GPI anchor are arbitrarily inserted into either the brush border or basolateral
membrane. Finally, the intracellular trafficking regulation ensures delivery of the right protein to
the right membrane (Schneeberger et al., 2018). All these processes mentioned above are major
factors that contribute to the development of polarized epithelial cells and thus support nutrient
and electrolyte transport. There is variation in the intestinal transport system, along the
cephalocaudal length of intestine and along the crypt-villus axis within the specific segment.
2.1.3. Na-dependent transporters in the intestine
Various transporters present in the membrane of the enterocytes facilitate its absorptive
capacity. These transporters might be present on any side of the enterocytes. Some of them are
coupled transporters, which transport two substrates at a time; whereas others are not, as they
transport only a single substrate. Among coupled transporters, we are mostly focused here on
Na-dependent transporters that are present in the brush border membrane of enterocytes and help
in the absorption of nutrients and electrolytes. Some of the Na-dependent transporters present in
the brush border membrane of enterocytes are Na-amino acids [Na-glutamine (B0AT1), Naalanine (NAcT)], Na-glucose (SGLT1), and Na-bile acid. All these Na-dependent transporters
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perform perfectly only when there is an optimum Na+ gradient maintained between the lumen
and enterocytes. Therefore, Na-K-ATPase, a basolateral membrane protein maintains the Na+
gradient that is necessary to drive Na-dependent transporters.
2.2. EICOSANOID BIOSYNTHESIS
2.2.1. Arachidonic acid synthesis
The lipolytic enzyme known as phospholipase A2 (PLA2) catalyzes the hydrolysis of cell
membrane phospholipids into free fatty acids and a lysophospholipid. PLA2 is a member of a
superfamily of enzymes consisting of various classifications. PLA2 has been broadly classified

Figure 6: Major pathways of arachidonic acid metabolism. Figure reproduced from (Harizi,
Corcuff, & Gualde, 2008).
into three types: secretory (sPLA2), cytosolic Ca2+-dependent (cPLA2), and cytosolic Ca2+independent (iPLA2) (Balsinde, Winstead, & Dennis, 2002). This systematic classification has
been based on various properties such as their amino acid sequences (Dennis, 1994; Six &
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Dennis, 2000), and specificity to the substrate and catalytic function (Balsinde et al., 2002). In
response to various stimuli such as cAMP, intracellular Ca2+ and other responses, PLA2 releases
20-carbon free fatty acid derivative known as arachidonic acid (AA) from the phospholipid, as
shown in Figure 6. Different eicosanoids products, including prostaglandins (PGs), leukotrienes
(LTs) and lipoxins are generated from this free-formed AA (Smith, DeWitt, & Garavito, 2000).
2.2.2. Arachidonic acid metabolism
Released arachidonic acids are metabolized into various eicosanoids products primarily
through three major oxidative pathways: cyclooxygenase, lipoxygenase, and cytochrome P450
pathways, which are explained below (Figure 6) (Moskowitz, Shapiro, Schook, & Puszkin,
1983).
2.2.2.1. Prostaglandin biosynthesis
Different kinds of PGs are produced by the enzyme cyclooxygenase, thus named the
cyclooxygenase pathway. Cyclooxygenase exists into two isoforms; cyclooxygenase-1 (COX-1)
and cyclooxygenase-2 (COX-2) (Mohajer & Ma, 2000). These enzymes catalyze the oxidation of
AA into PGG2 by inserting two oxygen molecules. The reduction of PGG2 converts it into
PGH2, which is further converted to other eicosanoids including prostaglandins (PGE2, PGD2,
PGF2), thromboxanes (TXA2, TXB2) and prostacyclin (PGI2) (DuBois, Eberhart, & Williams,
1996). COX-1, known as constitutive cyclooxygenase, basically maintains the mucosal integrity
by performing under the basic homeostatic conditions. However, COX-2 is expressed in
response to extrinsic or intrinsic stimuli; therefore the enzyme is named as inducible
cyclooxygenase (DuBois et al., 1996). COX-2 has been observed as a key player to initiate PGs
involved inflammation, resulting in swelling and pain (Mitchell & Evans, 1998), as well as
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participating in housekeeping functions (DuBois et al., 1996). These COX enzymes are the target
of various nonsteroidal inflammatory drugs (NSAIDs) for reducing inflammation.
2.2.2.2. Lipoxygenase biosynthesis
Lipoxygenase enzyme catalyzes the conversion of AA to various
hydroperoxyeicosateraenoic acids (HPETEs) and hydroxy eicosatetraenoic acids (HETEs) by
inserting one molecule of oxygen into AA (Lewis, Austen, & Soberman, 1990). 5-HETEs are
converted to LTA4 and subsequently converted to cysteinyl LTs (LTC4, LTD4, LTE4), LTB4,
and lipoxins (LXA4, LXB4). Similarly, 15-HPETEs are also converted to lipoxins (LXA4,
LXB4) (Harizi & Gualde, 2005).
2.2.2.3. Cytochrome P450 pathways
The cytochrome P450 epoxygenase pathway catalyzes the formation of epoxides and
HETEs by inserting a single atom of oxygen into AA (Capdevila et al., 1992).
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2.3. EICOSANOIDS IN CELLULAR SIGNALING
Eicosanoids produce various physiological alterations by binding to membrane receptors.
Binding with different receptors can result in various
changes, including increase or decrease in cytosolic
secondary messengers (cAMP, Ca2+), stimulation of
specific protein kinases, and changes in membrane
potential, subsequently modulating the physiological
state (Harizi et al., 2008) (Figure 7). Here, we will focus
on PG and LT signaling because of their importance in
the small intestine and its pathophysiological state.

Figure 7: Canonical pathway for eicosanoids signaling
2.3.1. Prostaglandin receptor signaling
PGs are secreted endogenously or during pathophysiological conditions, and mediate
their action by binding to specific membrane surface G-protein-coupled receptors (GPCRs)
(Dore, 2011; Liu, Qu, & Yan, 2015). To date, there exist at least nine prostanoid receptors in
mice and humans, as well as other splice variants (Narumiya & FitzGerald, 2001). Among these
nine receptors, four of the receptors (EP1, EP2, EP3, and EP4) bind to PGE2, two (DP1 and DP2)
bind to PGD2, FP specifically binds to PGF2a, and two bind to prostacyclin and thromboxane
(Hirai et al., 2001; Monneret, Gravel, Diamond, Rokach, & Powell, 2001). These receptors are
further classified into four different categories based on the specific isoform of G protein
involved in signaling. The first group, DP1, EP2, and EP4 receptors exert signaling through Gsmediated intracellular cAMP. EP2 and EP1 receptors are a second group that signal through Gq23

mediated intracellular Ca2+. EP3 falls into the third category, which regulates adenyl cyclase
activity through activation of Gi and Gs proteins. Unlike other receptors, the last group DP2 is a
member of a chemoattractant receptor family (Harizi et al., 2008; Hirai et al., 2001; Monneret et
al., 2001). Prostanoid receptors are mostly localized to the plasma membrane; however some are
found at the nuclear membrane as well (Bhattacharya et al., 1998; Bos, Richel, Ritsema,
Peppelenbosch, & Versteeg, 2004).
2.3.2. Leukotriene receptor signaling
LTs mediate signaling through four different kinds of GPCR. The first, BLT1, known as
a high-affinity LTB4 receptor, mediates signaling through cGMP via guanylyl cyclase. It also
mediates signaling through Gq and Gi (Yokomizo, Izumi, Chang, Takuwa, & Shimizu, 1997;
Yokomizo, Kato, Terawaki, Izumi, & Shimizu, 2000). The second, BLT2, reported as a lowaffinity LTB4 receptor, signals through Gq. The other two subtypes, CysLT1 and CysLT2, are
cysteinyl-LT receptors that are targeted by LTC4 and LTD4. CysLT1 is activated explicitly by
LTD4, whereas CysLT2 couples with both LTC4 and LTD4 (Kanaoka & Boyce, 2004).
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2.4. ROLE OF EICOSANOIDS IN THE SMALL INTESTINE
2.4.1. Eicosanoids in intestinal secretion
Large volumes of fluid are secreted into the lumen of the small intestine during digestion.
However, these fluids are reabsorbed back into the body. Fluids are secreted either by an
increase in luminal osmotic pressure or by PG-induced secretion. The mechanism by which a
PG-induced intestinal fluid secretion is mediated is through intracellular secondary messengers
such as cAMP, Ca2+, and acetylcholine. These secondary messengers induce intestinal secretion
by stimulating chloride and bicarbonate secretion and inhibiting sodium and chloride absorption
(Diener, Bridges, Knobloch, & Rummel, 1988a, 1988b; Powell, 1986; Racusen & Binder, 1980;
Rask-Madsen, Bukhave, & Lauritsen, 1988).
Various in vitro and in vivo studies reported that PG stimulates intestinal secretion
(Diener et al., 1988a, 1988b; Rask-Madsen et al., 1988). In rats, when PGE2 was administered
orally, it induced fluid secretion (Ruwart, Klepper, & Rush, 1979). Similarly, when PGE2 and
PGF2 were administered intravenously, they produced a secretory effect (Milton-Thompson,
Cummings, Newman, Billings, & Misiewicz, 1975). Like in other studies in which PG perfusion
was performed in different segments of animals (Canine jejunum, Rat jejunum and Cat ileum), it
yielded fluid secretion (Gaginella, 1990). The fluid secreted was rich in chloride but low in
calcium and sodium. In contrast, when PG synthesis was reduced by blocking COX with a
nonspecific COX inhibitor (indomethacin), it resulted in decreased fluid secretion (Ruwart et al.,
1979). This gives us the premise that reduction of PG endogenously may reduce the fluid
secretion in the small intestine.
As shown in Figure 7, secondary messengers when activated induce protein kinases,
which subsequently induce the phosphorylation of specific substrate proteins present in the
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cytoplasm or cell membrane. These activated substrate proteins urge apical membrane anionic
channels to open, resulting in secretion of chloride and bicarbonate anions into the lumen of the
small intestine (Diener et al., 1988a; Rask-Madsen et al., 1988). Thus, the secretion of chloride
ions creates an electrochemical gradient between serosal and mucosal layers, where the serosal
layer lacks anions and the mucosal layer is rich in anions. The electrochemical gradient thus
produced withdraws positively charged Na+ and water into the lumen through a paracellular
route, resulting in net fluid secretion in the lumen (Gaginella, 1990; Robert, Nezamis, Lancaster,
Hanchar, & Klepper, 1976; Turnberg, 1991).
Additionally, PG-mediated fluid secretion is also regulated through central and peripheral
nervous systems. PG induces the myenteric ganglia and cholinergic nerve terminal to produce
acetylcholine, which activates muscarinic receptors on enterocytes to increase the influx of Ca2+
into the cytoplasm. Thus, this increased Ca2+ stimulates Cl- secretion in the lumen (Ehrenpreis,
1981; Keast, 1987).
2.4.2. Eicosanoids in epithelial barrier
The monolayer of intestinal epithelial cells forms a cellular barrier that prevents harmful
pathogens, toxins, and immunogenic substances from reaching the subepithelial tissue. The
epithelial layer consists of a lipid bilayer at the apical membrane and tight junction (TJ) proteins
at the lateral surface (Figure 8), which obstruct such harmful molecules from reaching into the
systemic circulation (Anderson & Van Itallie, 1995; Madara, 1989). Although enterocytes form
the structural barrier, they also transport all molecules through two major pathways: transcellular
pathway - transport of molecules through the apical plasma membrane, and paracellular
pathway- transport of molecules laterally through TJ barrier (Ma, 1997). However, hydrophilic
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molecules which do not have specific transporter on membrane permeate through TJs rather than
lipid bilayers.

Figure 8: Pathways for transportation of molecules in small intestinal epithelial cells.
Therefore, the permeability of hydrophilic molecules is solely dependent on the relative
tightness of the TJ barrier (Ma, 1997; Madara, 1989). Thus, enterocytes in normal conditions
have a restrictive permeability and are referred to as non-leaky enterocytes, whereas enterocytes
with an increase in permeability during pathophysiological conditions are known as leaky
enterocytes.
Given this background, PGs also play a vital role in growth, maintenance and
fortification of the intestinal epithelial barrier. In one study, it has been reported that there is an
increase of PGE2 along with the maturation of the intestinal epithelial barrier (Gerstle, Seaton,
Kauffman, & Colony, 1994). In the same study, inhibition of PGE2 in mature animals (rats) by a
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COX-inhibitor (indomethacin) caused an increase in epithelial permeability (Gerstle et al., 1994).
Similarly, in another in vitro study, intestinal ischemia produced a marked increase in epithelial
permeability and reduced epithelial resistance in porcine ileum (Blikslager, Roberts, Rhoads, &
Argenzio, 1997). However, ischemic porcine ileum recovered back to normal after the exposure
to PGI2 and PGE2 (Blikslager et al., 1997). Moreover, cAMP and Ca2+ ionophores A23187 also
restored epithelial resistance, thus concluding that PG restoration reverts injured intestinal
epithelial back to normal. Consistent with the studies referenced above, various NSAIDs
(indomethacin, aspirin, and ibuprofen) have been shown to increase intestinal permeability and
hence decrease intestinal epithelial barrier function in humans (Bjarnason, Fehilly, Smethurst,
Menzies, & Levi, 1991; Bjarnason & Thjodleifsson, 1999).
2.4.3. Eicosanoids in mucosal protection
Mucosa provides an additional layer of defense against varying temperature, pH,
osmolarity, cytotoxic substances and bacterial products dispersed in the lumen (J. L. Wallace,
2008). Therefore, mucosal integrity and health are essential for protection against invasion of
noxious agents into the serosal layer. Numerous studies have reported that PG treatment has a
protective effect on mucosal damage (Robert, 1976, 1981). PGs are involved in mucus synthesis
and secretion, mucosal bicarbonate secretion, and fluid secretion. All of these processes help in
developing mucosal health and integrity by diluting noxious substances present in the intestinal
lumen (Leung, Miller, Reedy, & Guth, 1989; Lugea, Salas, Guarner, Azpiroz, & Malagelada,
1992).
Another important role of gastroduodenal mucosa is to secrete bicarbonate ions (HCO3-)
into the lumen to neutralize the acidic pH of the lumen from gastric acid which can reduce the
luminal pH to 1.5-2 (Bukhave, Rask-Madsen, Hogan, Koss, & Isenberg, 1990; Takeuchi, Yagi,
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Kato, & Ukawa, 1997). HCO3- secretion is regulated by endogenous PGs and the nervous
system. Moreover, Bukhave et al. have reported that patients with duodenal ulcers have reduced
HCO3- secretion and reduced endogenous PGs compared to normal patients, indicating that
endogenous PGs have a role in HCO3- secretion (Bukhave et al., 1990).
Additionally, endogenous PGs have also been involved in the proliferation of crypt cells.
In this regard, NSAIDs have shown to reduce villus height, crypt depth, and the number of
enterocytes (Uribe, Alam, & Midtvedt, 1992).
2.4.4. Eicosanoids in endothelial barrier
Endothelial cells are also an important source of eicosanoids. Endothelial cells have all
major pathways involved in the production of eicosanoids, including PGI2, PGE2, PGF2a,
thromboxane A2, LTs and hydroxy fatty acids (Schror, 1985). Eicosanoids produced by
endothelial cells have been shown to regulate vascular tone, cell locomotion, platelet activation
and cell proliferation (Schror, 1985). One of the deleterious effects of NSAID- or ethanolinduced GI mucosal injury has been due to damaged vasculature, resulting in increased vascular
permeability. This increased vascular permeability eventually leads to the formation of
interstitial edema, compression of blood vessels, thrombosis, ischemia, and stasis of blood
vessels (Szabo, 1987). In concordance with previous studies, PG treatment to NSAID-induced
GI injury improved vasculature and mucosal blood flow (L. Y. Cheung, 1980; Guth, 1986;
Szabo, 1987; Szabo & Goldberg, 1990). Therefore, PGs have been shown to protect GI injury
from NSAIDs by fortifying the endothelial barrier function.
2.4.5. Eicosanoids in intestinal muscle motility
Like other organ systems in which PGs stimulate the contraction of smooth muscles, PGs
are also involved in contraction of the small intestine, specifically initiation and propagation of
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migrating motor complex (MMC) in the intestine (Burakoff, Nastos, & Won, 1990; Karim &
Filshie, 1970). It has been reported that when human duodenum was exposed to PGE2, there was
a delay in initiation of MMC as well; PGE2 prevented propagation of initiated MMC (Tollstrom,
Hellstrom, Johansson, & Pernow, 1988). However, PGF2a has been found to induce motility in
the small intestine (Tollstrom et al., 1988).
The opposite effect of PGs in small intestinal motility is explained by various muscle
layers involved in contraction, specifically longitudinal and circular smooth muscle. PGE2 has
been shown to stimulate contraction of longitudinal smooth muscles, whereas it relaxes the
circular smooth muscles (Bennett & Fleshler, 1970; Waller, 1973). However, PGF2a has been
reported to stimulate both longitudinal and circular smooth muscle layers (Bennett & Fleshler,
1970; Waller, 1973).
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2.5. ROLE OF EICOSANOIDS IN INFLAMMATORY BOWEL DISEASE (IBD)
Besides being involved in maintaining normal homeostatic intestinal physiology,
eicosanoids also play a crucial role during pathophysiological conditions. During
pathophysiological conditions, eicosanoids might alter intestinal motility, mucosal growth and
development, endothelial functions, and transport processes (electrolyte and nutrient) involved in
intestinal secretion, and absorption. However, in this section we will focus on the enterocyte
transport process in regard to inflammatory bowel disease (IBD). IBD is known as inflammation
of the GI tract and includes ulcerative colitis and Crohn’s disease. Ulcerative colitis is primarily
the inflammation of the colon whereas Crohn’s disease is the inflammation of the small intestine
and/or colon.
2.5.1. Role of Prostaglandin
As mentioned before, due to the diverse role of PGs in the intestine, many elaborative
studies are devoted to the understanding of the role PGs play in IBD. It has been reported that
there is increased production of cyclooxygenase products during IBD: about ~ 100% increase of
PGE2 and thromboxane and ~ 50% increase in prostacyclin (Ligumsky et al., 1981;
Rachmilewitz, Ligumsky, Haimovitz, & Treves, 1982; Sharon & Stenson, 1984). During
intestinal pathological conditions like Crohn’s disease or ulcerative colitis, there is excessive
production of PGs causing diarrhea (Hawkey, Karmeli, & Rachmilewitz, 1983; Hawkey et al.,
1998). The cause of diarrhea may be due to the following two mechanisms: 1) PG-mediated
secretion of intestinal fluid, and 2) PG-induced stimulation of small intestinal motility. The
increase in PGs level during Crohn’s ileitis is due to up-regulation of COX-2 but not COX-1
expression (Hendel & Nielsen, 1997; Singer et al., 1998). Singer et al. has reported that COX-1
expression is limited to crypt cells of the small intestine during normal and inflamed condition;
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whereas, COX-2 expression was elevated in Crohn’s ileitis and limited to villus epithelium.
Furthermore, COX-2 was also seen to be markedly increased in mononuclear cells in Crohn’s
ileitis. However, the increased level of COX-2 was relatively higher in epithelial cells compared
to mononuclear cells present in lamina propria (Singer et al., 1998). These findings suggest that
COX-2 induced PG is involved in the induction of intestinal inflammation. However, in clinical
studies, inhibiting COX with NSAIDs did not recover the patient from IBD, rather aggravated
the situation (Bjarnason & Peters, 1989; Kaufmann & Taubin, 1987; Rampton & Sladen, 1981).
2.5.2. Role of Leukotrienes
The role of LTs was observed much later than the role of PGs in IBD. Actually, the role
of LTs in the context of IBD gathered attention after Musch et al. reported that LOX product
stimulates colonic secretion (Musch, Miller, Field, & Siegel, 1982). Biopsy samples of active
IBD patients showed a remarkable rise in the lipoxygenase products 5-HETE and LTB4 (Sharon
& Stenson, 1984), and the mechanism behind the increase of LTB4 was due to reduced activity
of w-hydroxylase and increased activity of 5-LOX (Ikehata et al., 1995). Peskar et al. also
reported there was a significant increase in peptide LTs (LTC4, LTD4, LTE4) in IBD patients
(Peskar, Dreyling, Peskar, May, & Goebell, 1986). The IBD patients treated with NSAIDs
showed more aggravating conditions compared to non-treated patients (Hudson, Balsitis, Everitt,
& Hawkey, 1993). The mechanism behind the aggravating situation was due to NSAIDs
shunting AAs to a remarkable increase in LTB4 production (Hudson et al., 1993).
In several investigations with animal models of IBD, there has been success in treating IBD with
inhibitors of LT (J. L. Wallace et al., 2011). However, when IBD patients were treated with the
selective inhibitor of LTB4 (MK-591), it did not produce a significant improvement in the
clinical activity of the patients (Roberts et al., 1997). Likewise, when patients were treated with a
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5-LOX inhibitor (zileuton), the IBD group had the same remission rate compared to the placebo
group (Hawkey, Dube, Rountree, Linnen, & Lancaster, 1997). All these studies indicate that
there might be a possibility that LT might play a role in IBD, but the mechanisms need to be
explored further.
2.5.3. Role of eicosanoids in Intestinal epithelial transporters
The small intestine is the major site of nutrient and electrolyte absorption. However,
ample evidence exists to show that Na-coupled co-transporters including Na-glutamine (System
B0 amino acid transporter 1 (B0AT1)), Sodium-alanine co-transporter (NAcT), Soidum-Glucose
transporter 1 (SGLT1) and Na-neutral amino acid co-transporter are reduced in absorptive villus
cells during in vivo or in vitro IBD-related studies (Table 2). The mechanism of reduced cotransporter activity is confined to the specific co-transporters, either due to a decrease in protein
expression or a decrease in affinity (1/Km) (Table 2). Unlike villus cells, the Na-glutamine
(System N transporter 2 (SN2)) co-transporter in crypt cells is stimulated during IBD, and the
mechanism is an increase in affinity of the co-transporter rather than the change in expression of
the protein (Table 2). In all of these studies, at the intact cell level, there is a positive correlation
between Na-dependent transporter and Na-K-ATPase, indicating that the reduced or increased
activity of the Na-dependent co-transporter is in part due to the activity of Na-K-ATPase.
Moreover, there is a differential effect on isoforms of Na/H exchanger during IBD. There
are mixed reports with increased or decreased activity of NHE1 (performs housekeeping
function), whereas NHE3 (performs the absorptive function) appeared to have reduced activity
during IBD (Magalhaes, Cabral, Soares-da-Silva, & Magro, 2016).
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2.5.3.1 Role of eicosanoids in Na-K-ATPase
Widespread studies in humans, animals, and cell lines provide robust evidence suggesting
that there is decreased Na-K-ATPase during IBD or when cells are exposed to IBD-associated
proinflammatory factors (Table 3 & 4). The mechanism is mostly due to reduced levels of a1
and b1 isoforms, resulting in a decrease in the number of functional pumps in the membrane.
However, there are alternative mechanisms responsible for the reduction of Na-K-ATPase
activity: 1) stimulation of the PKC-STAT1 phosphorylation downstream signaling pathway
without changing the level of Na-K-ATPase protein, and 2) lack of Na-K-ATPase to properly
adhere to membranes due to downregulation and depolarization of ankyrin protein (Table 3 & 4).
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Model/ Cell Types

Related Methods

Major Findings

Mechanisms

References

Rabbit IBD
(Villus cells)

Radioactive uptake,
Inorganic phosphate (Pi)
measurement
WB

¯ Na-bile acid (ASBT)/ ¯ Na-K-ATPase in IBD
Whereas, Glucocorticoid (Methylprednisolone)
treatment reversed the IBD effect.

ASBT - ¯ Vmax /  Km
¯ Protein expression in IBD
ASBT -  Vmax / ¯ Km
 Protein expression in treated

(Coon, Kekuda, Saha, &
Sundaram, 2010)

Rabbit treated with cNOS
inhibitor (L-Name)

¯ SGLT-1(Na-glucose)/  Na-K-ATPase / ÛNAcT
(Na-neutral amino acid)

Rabbit IBD
(Crypt cells)

Radioactive uptake,
Pi measurement, WB

 SN2 (Na-glutamine)/  Na-K-ATPase in IBD
Whereas, Glucocorticoid (Methylprednisolone)
treatment reversed the IBD effect.

Rabbit IBD (Crypt cells)
Treated with COX and LOX
inhibitors

Radioactive uptake,
Pi measurement, WB

Rabbit IBD (Villus cells)
Treated with COX and LOX
inhibitors

Radioactive uptake,
Pi measurement, WB

ATK-PLA2 inhibitor-Reversed IBD effect
PRX- COX inhibitor-Did not reverse
MK886- LOX inhibitor-Reversed
LOX pathway mediated stimulation of SN2 in crypt
cells during IBD
ATK-PLA2 inhibitor-Reversed IBD effect
PRX- COX inhibitor- Reversed IBD effect
MK886- LOX inhibitor- Did not reverse
COX pathway mediated reduction of B0AT1 in
crypt cells during IBD

SGLT1 mechanism- ¯Km
ÛmRNA expression
ÛProtein synthesis
B0AT1- ¯ Vmax / Û Km
¯ Protein expression in IBD
B0AT1- Vmax / Û Km
 Protein expression in treated
Û Vmax, ¯ Km and ÛProtein
expression in IBD
Û Vmax,  Km and ÛProtein
expression in treated
¯ SN2 / ¯ Na-K-ATPase in treated
animal. Because of ÛVmax,  Km
and ÛProtein expression of SN2

(Coon, Kim, Shao, &
Sundaram, 2005)

Rabbit IBD
(Villus cells)

Radioactive uptake,
Pi measurement
WB, qRT-PCR
Radioactive uptake,
Pi measurement, WB

 B0AT1, Na-K-ATPase activity in
treated animal. Because of  Vmax, Û
Km and  protein expression

(Arthur, Singh, &
Sundaram, 2018)

Rabbit IBD

Radioactive uptake,
Pi measurement, WB

¯ NAcT (Na-alanine) / ¯Na-K-ATPase in IBD
Whereas, Glucocorticoid (Methylprednisolone)
treatment reversed the IBD effect.

 NAcT activity in treated animal.
Because of ¯Km and ÛmRNA level,

(Sundaram, Wisel, &
Coon, 2007)

IEC-18 cells
Treated with LTD4 (1 uM)

Radioactive uptake,
Pi measurement, WB

¯ NAcT (Na-alanine) / ÛNa-K-ATPase

NAcT- ÛVmax,  Km and
Û protein expression

(Talukder, Kekuda, Saha,
& Sundaram, 2008)

IEC-6
Treated with PGE2 (1 nM)

Radioactive uptake,
Pi measurement, WB

¯SGLT-1 / ÛNa-K-ATPase

SGLT-1- ¯ Vmax and decrease in
protein synthesis

(Talukder, Griffin, Jaima,
Boyd, & Wright, 2014)

¯ B0AT1(Na-glutamine)/ ¯Na-K-ATPase in IBD
Whereas, Glucocorticoid (Methylprednisolone)
treatment reversed the IBD effect.

(Arthur, Saha, Sundaram,
Kekuda, & Sundaram,
2012; Saha, Arthur,
Kekuda, & Sundaram,
2012)

(S. Singh, Arthur, &
Sundaram, 2018)

Table 2: Studies on small intestinal epithelial Na-dependent transporters (Na-bile acid, Na-glucose, Na-glutamine and Na-KATPase) in animal IBD models or animal cells. WB- Western blot, COX- cyclooxygenase, LOX- Lipoxygenase, ATK-Arachidonyl
Trifluoromethyl Ketone, PRX- piroxicam, Affinity of transporter (1/Km), PGE2- Prostaglandin E2, LTD4- Leukotriene D4, IECIntestinal epithelial cell (Rat ileum). Û-no change, ¯- down regulation in activity and expression,  up-regulation in in activity and
expression.
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Model/
Cell Types

Related Methods

Colonic UC biopsies

N/A

Colonic biopsies from
healthy patients

Inorganic phosphate
release (Pi)

Colonic UC or CD
biopsies
Rectal UC or CD

Coupled optical assay of
Na-K-ATPase activity
Pi measurement

Distal colon inflamed
mucosa of UC or CD

Isc measurement (activity)
under mystatin and [Na+]
variation
Coupled optical assay
(activity) and 3H Ouabain
binding assay
WB, IHC, NB

Sigmoid biopsies of
UC, CD or normal
patients
Sigmoid and proximal
rectal UC biopsies
Mucosa of sigmoid
and proximal rectal
biopsies of UC
Inflamed ileal and
sigmoid mucosa of
UC or CD biopsies
Caco-2 Cell line

Major Findings
(Function)

Mechanisms

References

¯Na-K-ATPase was lower in UC biopsies
compared to normal
Û Na-K-ATPase
HETEs, LTB4, ROS

N/A

¯Na-K-ATPase

N/A

¯Na-K-ATPase in patients with UC with severe
rectal inflammation
Û Na-K-ATPase in patients with mild UC or no
rectal inflammation
¯Na-K-ATPase

(Allgayer, Kruis,
Paumgartner, et al., 1988)
(Ejderhamn, Finkel, &
Strandvik, 1989)

¯ number of pumps

(Sandle et al., 1990)

 Na-K-ATPase

(Scheurlen, Allgayer,
Hardt, & Kruis, 1998)

Glucocorticoids reduced diarrheal symptoms in
IBD and shows anti-inflammatory effects

N/A

(Rachmilewitz, Karmeli,
& Sharon, 1984)
(Allgayer, Kruis, &
Erdmann, 1988)

¯ a1 isoform protein level
Û a1 isoform mRNA level
¯ a1 and b1 isoform protein level
Û a1 and b1 isoform mRNA level

(Greig, Boot-Handford,
Mani, & Sandle, 2004)

WB-WC, IHC

¯ a1 isoform protein level

(Sullivan et al., 2009)

WB-PM, Pi measurement

IFN-g reduces ¯Na-K-ATPase in time and
concentration dependent manner

Caco-2 Cell line

WB-PM, Pi measurement

TNF-a reduces ¯Na-K-ATPase through PGE2

Caco-2 Cell line

WB-PM, Pi measurement

Long term treatment of IFN-g ¯Na-K-ATPase,
Whereas TGF-b Û Na-K-ATPase

WB-WC, IHC, NB

Û Protein level
PKC-STAT1 phosphorylation
RAF-1, MEK, ERK2 and p38
pathways involved
¯Protein level

(Magro, Fraga, Ribeiro,
& Soares-da-Silva, 2004)
(Markossian &
Kreydiyyeh, 2005)
(Magro, Fraga, Ribeiro,
& Soares-da-Silva, 2005)

Table 3: Studies on Na-K-ATPase in human IBD or human intestinal epithelial cells/tissues. UC-Ulcerative colitis, CD- Crohn’s
disease, IBD-inflammatory bowel disease, WB-WC-Western blot in whole cell, WB-PM-Western blot in plasma membrane, IHCimmunohistochemistry, NB- northern blotting, HETEs- hydroxyeicosatetraenoic acid, LTB4- Leukotriene B4, PGE2 -Prostaglandin
E2, Isc- Short-circuit current. Û-no change, ¯- down regulation in activity and expression,  up-regulation in activity and expression.
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Model/
Cell Types

Related Methods

Major Findings
(Function)

Ileal enterocytes isolated from
TNBS treated rats

N/A

¯Na-K-ATPase compared to
normal

Jejunal and ileal mucosa of
healthy murine
Isolated Jejunal enterocytes of
healthy rat

Inorganic phosphate
release (Pi)
WB-PM, radiolabeled
ouabain binding and Pimeasurement
WB-PM, and Pimeasurement
WB-PM, and Pimeasurement
WB-PM, and Pimeasurement

IFN-g - ¯Na-K-ATPase

Isolated colonocytes of healthy
rats
Isolated colonic surface and
crypt cells of healthy rats
Mucosa of colon, jejunum and
terminal ileum of TNBS-treated
rats
Colonic crypts of healthy rats
Colonic mucosa of NHE3-/- mice
Colonic mucosa of DSS- and
TNBS-treated rats
Colon and ileum of DSS-treated
mice
Villus cells from rabbit IBD
model

Isc activity
RT-qPCR
WB-WC, IHC
WB, RT-qPCR
WB-PM, WB-WC, IHC,
RT-qPCR and Pimeasurement

Mechanisms

References
(Wild & Thomson, 1995)

IL-1b - ¯Na-K-ATPase

¯ a1 and b1 isoform protein
and
mRNA levels
Due to nitric oxide-dependent
manner
¯ a1 isoform protein level

IL-1b - ¯Na-K-ATPase

¯ a1 isoform protein level

(Kreydiyyeh & Al-Sadi, 2002b)

TNF-a reduces ¯Na-K-ATPase
through PGE2
¯Na-K-ATPase on proximal
colon
 Na-K-ATPase on distal colon
NH2Cl - Na-K-ATPase

¯ a1 isoform protein level

(Markossian & Kreydiyyeh, 2005)

¯ a1 isoform protein level in
proximal colon

(Magro, Fraga, & Soares-da-Silva,
2005)

N/A

(Schultheiss, Lan Kocks, & Diener,
2005)
(Laubitz et al., 2008)
(Sullivan et al., 2009)

 a1 isoform mRNA level
Û a1 isoform protein level in
colitis model
¯ a1 isoform protein level
Û a1 isoform mRNA level
Û a1 and b1 isoform protein
mRNA level in whole cell, but
¯ a1 and b1 isoform protein
mRNA level in plasma membrane

(Yoo et al., 2000)
(Kreydiyyeh & Al-Sadi, 2002a)

(Hirota & McKay, 2009)
Downregulation and
depolarization of ankyrin
protein

(Saha et al., 2015)

Table 4: Studies on Na-K-ATPase in animal IBD or animal intestinal epithelial cells/tissues. IBD-inflammatory bowel disease,
WB-WC-Western blot in whole cell, WB-PM-Western blot in plasma membrane, IHC-immunohistochemistry, IFN-g- interferon
gamma, IL-Interleukin, and Isc- Short-circuit current. Û-no change, ¯- down regulation in activity and expression,  up-regulation in
activity and expression.
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3.1. ABSTRACT
The most important function of the mammalian intestinal cells is the absorption of
nutrients, electrolytes, and water. In the mammalian small intestine, nutrients are primarily
absorbed via Na-nutrient co-transport processes on the brush border membrane (BBM) of
primarily absorptive villus cells. The necessary favorable transcellular Na gradient for the proper
functioning of Na-dependent nutrient co-transporters is provided by Na-K-ATPase on the
basolateral membrane of enterocytes. In the intestine, as a primarily secretory crypt cell matures
to a primarily absorptive villus cell, it acquires all the BBM Na-solute co-transport processes that
are dependent on Na-K-ATPase. Indeed, as cells mature from crypt to villus, Na-K-ATPase
doubles, to accommodate for the increased BBM Na-dependent nutrient absorption. However,
the mechanism of increase of Na-K-ATPase during growth and maturation of intestinal cells
from the crypt to villus is not known. Therefore, this study aimed to determine the mechanisms
involved in the functional transition of Na-K-ATPase during the maturation of crypt to villus
cells. Rat intestinal epithelial cell (IEC-18 cell line) is an excellent model of in vitro crypt (0 day)
to villus (4 days) maturation. Na-K-ATPase activity, as measured by inorganic phosphate release
and 86Rb+ uptake, gradually increased as the cells matured in vitro from day 0 through day 4 of
post-confluence. mRNA abundance and Western blot studies showed no change in the levels of
Na-K-ATPase subunits α1 and β1 from 0 to 4 days post-confluence. However, Na-K-ATPase α1
phosphorylation levels on serine and tyrosine, but not threonine, residues gradually increased as
cells matured in vitro from day 0 to 4. These data indicate that as enterocytes mature from cryptlike to villus-like in culture, the functional activity of Na-K-ATPase increases secondary to
altered affinity to accommodate the functional preference of the intestinal cell type without
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changing its membrane expression levels. This altered affinity is likely due to phosphorylation of
the α1 subunit, specifically at serine and tyrosine residues.
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3.2. INTRODUCTION
An essential function of the mammalian small intestine is nutrient absorption (Gerbe,
Legraverend, & Jay, 2012). While the intestinal epithelium is composed of multiple specialized
cells types including goblet cells, enteroendocrine cells, Paneth cells, and enterocytes (de Santa
Barbara, van den Brink, & Roberts, 2003), only enterocytes are responsible for nutrient
absorption from the intestinal lumen. The enterocytes are comprised of undifferentiated crypt
cells, which proliferate and differentiate to mature villus cells (Babyastsky & Podolsky, 1999).
Nutrient, electrolyte and fluid absorption primarily occur by the villus cells while the crypt cells
are thought to be primarily secretory.
During the differentiation process, enterocytes acquire more transporters on both sides
and are physiologically able to absorb more nutrients compared to undifferentiated crypt cells.
Among the acquired transporters, Na-K-ATPase, a basolateral membrane (BLM) transporter,
plays an important role in regulating ionic homeostasis, cell volume and maintaining membrane
potential (Kay, 2017). Na-K-ATPase transports three Na+ out of the cell in exchange for two K+
into the cell, thus maintaining a high level of intracellular K+ and low intracellular Na+
concentration (Kaplan, 2002). This establishes a Na+ gradient that is responsible for driving other
secondary transport processes across the brush border membrane (BBM). Transport of different
ions (H+, Ca2+, Cl-, PO42-, SO42-), nutrients like glucose, amino acids and vitamins, certain
nucleic acids, bile acids, and neurotransmitters across the plasma membrane are all dependent on
Na-K-ATPase activity (Skou, 1990; Skou & Esmann, 1992). Previous studies have shown that
Na-nutrient co-transport mechanisms in the BBM, namely Na-glucose (SGLT1), Na-alanine
(NAcT), Na-glutamine (B0AT1), Na-bile acid (Apical sodium bile acid transporter (ASBT)) and
Na-adenosine (Divalent metal transporter 1 (DMT1)) that depend on the BLM Na-K-ATPase for
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their optimal activity, are inhibited. Further, their inhibition in villus cells in a rabbit model of
inflammatory bowel disease (IBD) (Ejderhamn et al., 1989; Rachmilewitz et al., 1984; Sundaram
& West, 1997) is at least in part secondary to altered Na extruding capacity of the cell from
diminished Na-K-ATPase activity. Therefore, Na-K-ATPase plays a crucial role in nutrient
absorption and maintenance of intestinal health.
The Na-K-ATPase enzyme consists of various subunits: alpha (α), beta (β) and gamma
(g) subunits (Kaplan, 2002). The α and β subunits are ubiquitously present and are important for
the activity of Na-K-ATPase (G. E. Shull, Lane, & Lingrel, 1986; G. E. Shull, Schwartz, &
Lingrel, 1985), while the g-subunit is an optional subunit and its expression is restricted to
certain tissues (Beguin et al., 1997). Of these subunits, α subunit does the catalytic function of
the transporter (G. E. Shull et al., 1985), whereas other subunits (β and g) are responsible for the
regulatory function of the α subunit (Arystarkhova, Wetzel, Asinovski, & Sweadner, 1999;
Geering, 2001). The α subunit is a transmembrane protein having intracellular Na+, ATP and
phosphate binding sites, and extracellular K+ binding sites (Kaplan, 2002). The β subunit is
important for the proper folding of the α subunit and its translocation to the plasma membrane
(Ackermann & Geering, 1990; McDonough, Geering, & Farley, 1990). At least four isoforms of
the α subunit (α1, α2, α3, and α4) and three isoforms of the β (β1, β2, and β3) subunit are known.
These isoforms are expressed in a tissue-specific manner (Blanco, Melton, Sanchez, & Mercer,
1999; Kaplan, 2002; Mercer, 1993). The combination of different isoforms of the α and β
subunits make up a series of Na-K-ATPase isoenzymes (Blanco & Mercer, 1998b). Each
isoenzyme has different functional properties and they are expressed differentially in tissue- and
cell specific-manners (Jewell et al., 1992). Of these isoforms, α1 and β1 are ubiquitously present
in epithelial cells and are also present in the mucosa of the intestine (Saha et al., 2015).
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Na-K-ATPase activity is tailored to change according to the physiological requirements
of the cell. There are several mechanisms that regulate Na-K-ATPase activities. For example,
availability of the substrate (Na+, K+ and ATP), the amount of the enzyme at the plasma
membrane, which can be modified by changes in the rate of synthesis or degradation of the
individual Na pump polypeptide, and movement of the pump from cytoplasmic vesicles to the
plasma membrane by exo/endocytotic vesicular transport (Blanco et al., 1998). Besides these
mechanisms, Na-K-ATPase activities at the cell surface are directly regulated by direct
phosphorylation and dephosphorylation by protein kinases and protein phosphatases (Bertorello
& Katz, 1993; Ewart & Klip, 1995; McDonough & Farley, 1993). Alterations in the
phosphorylation levels of the α and regulatory g subunits are known to change the affinity and
therefore the activity of the transporter.
As mentioned above, published studies using in vivo models have shown that the Na-KATPase functional activity varies depending on the cell type and function: rabbit villus cells that
have the primary function of sodium-dependent nutrient absorption have twice the amount of
Na-K-ATPase function compared to the crypt cells that have minimal absorptive capacity (S.
Singh et al., 2015). However, the mechanism(s) underlying the alteration of Na-K-ATPase
function during maturation of crypt to villus cell is not known at this time. Therefore, the aim of
this study is to explore the mechanism(s) underlying the alteration of Na-K-ATPase activity
during maturation of intestinal epithelial cells.
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3.3. MATERIALS AND METHODS
3.3.1. Cell culture
Rat small intestinal epithelial cells (IEC-18, American Type Culture Collection), between
passages 5 and 20, were used for all of the experiments. Cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100
U/l human insulin, 0.25 mM β-hydroxybutyric acid and 100 U/ml of penicillin and streptomycin.
These cells were cultured in a humidified atmosphere of 10% CO2 at 37°C. The cells were fed
with fresh medium every other day. When the cells reached 100% confluence, it was considered
as 0 day, and cells were grown until 4 days post-confluence. Experiments were conducted in 0day, 1-day, 2-day, 3-day, and 4-day post-confluent cells.
3.3.2. Alkaline phosphatase activity (ALP) assay
The activities of ALP were determined using an enzyme assay kit, according to the
manufacturer’s protocol (Abcam#83369, Alkaline phosphatase assay kit, colorimetric). ALP
activity was calculated as picomole/min/ml from the cells that were harvested between 0 and 4day post-confluence.
3.3.3. Na-dependent glucose uptake studies
To determine the Na-dependent glucose transport in IEC-18 cells, glucose uptake studies
were performed on cells grown on transwell inserts (0.4 µ , Thermoscientific #140620) in 24
well plates. Cells were rinsed once with warm wash buffer (130 mM NaCl, 5mM KCl, 1mM
MgSO4, 2 mM CaCl2, 20 mM HEPES and pH adjusted to 7.4) and incubated with the same
buffer for 10 mins. After the incubation, wash buffer was removed from the wells and replaced
with a reaction mixture containing a trace amount of [3H] OMG in Na-HEPES buffer with and
without phlorizin (SGLT1 inhibitor). The reaction was stopped after two minutes with cold wash
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buffer (130 mM NaCl, 5mM KCl, 1mM MgSO4, 2 mM CaCl2, 20 mM HEPES, 10mM DGlucose and pH adjusted to 7.4), and the cells were then washed twice with the same buffer.
Cells were lysed by incubating them with 1M NaOH for 20 mins at 70°C. The lysed cells from
each well were then mixed with 5 ml of Ecoscint A (National Diagnostics). The vials were kept
in darkness overnight and radioactivity retained by the cells was determined in a Beckman
Coulter 6500 scintillation counter.
3.3.4. Crude plasma membrane isolation
Plasma membrane (crude) was prepared from cells according to the method of
Havrankova et al. (Havrankova, Roth, & Brownstein, 1978). Briefly, 100 mg cells were
homogenized in 5ml of 1mM NaHCO3 and centrifuged at 600 x g for 30 min. The supernatant
was collected and centrifuged for 30 min at 20,000 x g. The membrane pellets were washed
twice with 1mM NaHCO3. The final pellets were resuspended in 0.04 M Tri-HCl buffer (pH 7.4)
containing 0.1% BSA. All the procedures mentioned above were carried out at 4oC.
3.3.5. Na-K-ATPase activity assay
Na-K-ATPase activity was measured as Pi liberated in cellular homogenates and crude
plasma membrane fractions from the cells that were harvested 0-4 days post-confluence
according to the protocol of Forbush et al. (Forbush, 1983). Enzyme-specific activity was
expressed as nanomoles of Pi released per milligram protein per minute.
3.3.6. Determination of Na-K-ATPase activity and kinetics by 86Rb+ uptake
Uptake studies were performed in cells grown on transwell inserts in 24 well plates. IEC18 cells were plated with approximately 1×105 cells. Uptake studies for Na-K-ATPase were
done using radioactive Rubidium (86Rb+, Perkin Elmer). Cells were incubated for 1hr in serumfree DMEM media at the aforementioned conditions. The cells were subsequently washed with
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serum-free media and incubated for 10 min at 37°C with 20 μM monensin (in serum-free
DMEM) added to both the apical and basolateral sides. The cells were then washed with serumfree DMEM. Uptake of 86Rb+ was started by incubating the cells for 15 mins in a reaction
mixture (Serum-free DMEM) containing ~1 μCi/ of 86Rb+ well added to the basolateral side of
the cells in the presence and absence of ouabain (1mM).
For Na-K-ATPase kinetics, after incubation with serum-free DMEM for 1hr, the cells
were subsequently washed with an incubation buffer (130 mM NaCl, 5mM KCl, 1mM MgSO4, 2
mM CaCl2 and 20 mM HEPES) and incubated for 10 min at 37°C in the incubation buffer with
20μM monensin on both sides of the membrane. Then cells were washed with a wash buffer (130
mM NaCl, 1mM MgSO4, 2 mM CaCl2, 20 mM HEPES and 5 mM mannitol) on both sides. NaK-ATPase kinetic studies were then performed in cells by incubating them for 30 secs with
reaction mixtures (130 mM tetramethylammonium chloride, 1mM MgSO4, 2 mM CaCl2, 20 mM
HEPES, 5 mM mannitol and 86Rb+ (~1 μCi/ well)) containing different concentrations (0.05-2
mM) of RbCl added to the basolateral side of the membrane in the presence and absence of
ouabain (1 mM).
For both uptake and kinetics experiments, the reaction was then stopped by the addition
of ice-cold MgCl2. The cells were then washed three times with MgCl2 and lysed with 800 μl of
1N NaOH by incubating them for 30 min at 70°C. The lysed cells from each well were then
mixed with 5 ml of Ecoscint A (National Diagnostics). The vials were kept in darkness overnight
and radioactivity retained by the cells was determined in a Beckman Coulter 6500 scintillation
counter. The absolute Na-K-ATPase activity was calculated by subtracting 86Rb+ uptake in the
presence of ouabain from that in the absence of ouabain.
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3.3.7. RNA isolation and qRT-PCR
RNA was isolated from 0-4 days post-confluent cells by using the RNeasy mini kit
obtained from Qiagen. The real-time quantitative PCR (qRT-PCR) was performed using an
isolated total RNA by a two-step method. First, total RNA was used to synthesize
complementary deoxyribonucleic acid (cDNA) using SuperScript III (Invitrogen Life
Technologies). Then, newly synthesized cDNA was used as a template to perform real-time PCR
using TaqMan universal PCR master mix from Applied Biosystems (Foster City, CA) according
to the manufacturer’s protocol. Rat-specific Na-K-ATPase α1 and Na-K-ATPase β1 primers and
probes were used for the qRT-PCR studies. In addition, the rat-specific β-actin primer was used
to normalize the expression levels of mRNA in the samples.
3.3.8. Immunoprecipitation
Immunoprecipitation (IP) assays were conducted in order to investigate the
phosphorylation level of Na-K-ATPase α1 present in the plasma membrane. Cells were first
rinsed with PBS, scraped and collected in PBS, and pelleted by brief low-speed centrifugation
(800 rpm). The collected pellet was further used for plasma membrane isolation as mentioned
above. The prepared plasma membrane fraction was sonicated and dissolved in 200 ul of lysis
buffer (T-per Buffer, Thermo scientific) with protease inhibitors (Thermo Scientific). Plasma
membrane protein was further diluted to 1 μg/μl in a microcentrifuge tube with T-per buffer and
placed on a rocking shaker at 4°C with 2 μg of Anti-Na-K-ATPase α1 antibody overnight.
Antibody-protein complexes formed were captured by adding 50 μl of washed protein G agarose
bead slurry (Thermo Scientific, Catalog # 16-266) with rotation at 4°C for 2 hours. The agarose
beads with the protein-antibody complex were collected by centrifugation (14,000 x g) and
washed three times with ice-cold lysis buffer. These agarose beads were resuspended in 2X
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sample loading buffer and incubated at 37°C for 15 minutes. The beads in sample loading buffer
were vortexed, and the supernatant was used for Western blot analysis.
3.3.9. Western blot analysis
Western blot analysis was performed in the whole cell lysate and plasma membrane
preparations. An equal amount of protein (20 μg) was denatured in sample buffer (Laemmli
sample buffer, BIO-RAD #3100010639) and separated by electrophoresis on a 8%-12% gradient
gel. Proteins on the gel were transferred to a polyvinylidene fluoride membrane which was
blocked with 5% dry milk or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1%
Tween-20 and then incubated with one of the following primary antibodies, overnight at 4°C:
Na-K-ATPase α1 (Millipore, # 05-369); Na-K-ATPase β1 (Abcam, ab2873); p-Serine (Abcam,
ab9332); p-Threonine (Abcam, ab179530); p-Tyrosine (Abcam, ab9337); p-Na-K-ATPase α1Ser23 (Cell Signaling Technology, #4006) and p-Na-K-ATPase α1-Ser16 (Cell Signaling
Technology, #4020). The membrane was washed three times with TBST followed by TBS. The
membrane was then incubated with secondary antibody for 1hr. Enhanced chemiluminescence
(ECL) western blotting detection reagent (GE Healthcare Bio-Sciences, Piscataway, NJ) was
used to detect the immobilized protein. The chemiluminescence was detected using a FluorChem
M instrument (Alpha Innotech, San Leandro, CA) and the intensity of the bands were analyzed
by its software. β-actin was used to normalize the expression levels in cellular homogenate.
3.3.10. Protein determination
Total protein was measured by the Lowry method using the Bio-Rad protein assay kit
(Hercules, CA). BSA was used as a standard.
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3.3.11. Statistical analysis
All groups presented have at least n=3 per group repeated with a different passage. The
values are presented as mean ± SEM, and significant values of P<0.05 were taken to indicate
statistical significance. All of the data were analyzed using one-way or two-way analysis of
variance (ANOVA) using GraphPad Prism software (San Diego, CA).
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3.4. RESULTS
3.4.1. Alkaline phosphatase (ALP) levels during cell growth
To confirm the cell growth and maturation in IEC-18 cells, alkaline phosphatase activity
was measured from cells collected from 0-day to 4-day post confluence (Figure 9). The highest
level of alkaline phosphatase activity was observed at 4-day post-confluence (1536±44.16
picomole/min.ml), whereas the lowest level activity (1092±5.432 picomole/min.ml) was
observed at 0-day post-confluence. This trend of increasing alkaline phosphatase activity
demonstrates that cells mature as they grow from 0-day post confluence (crypt-like) to 4-day
post confluence (villus-like).

Figure 9. Alkaline phosphatase (ALP) activity to validate cell maturation as IEC-18 cells
grow. Values are represented as means ± SEM, n=4. Values not sharing common superscripted
letters are significantly different at P < 0.001.
3.4.2. Na-dependent glucose uptake during cell growth
As enterocytes mature from crypt to villus, physiological alterations are accompanied by
the appearance of different transporters in the BBM. Specifically, the Na-glucose co-transporter
SGLT1 appears as enterocytes mature from crypt to villus. Similar to in vivo observations
(Hwang, Hirayama, & Wright, 1991), we also found that Na-dependent glucose uptake increased
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almost three-fold as cells matured from crypt-like to villus-like. Figure 10 shows that minimal
SGLT1 activity (92.53±13.35 picomole/mg protein.min) was at 0-day ost-confluence. There was
a steady and robust increase in SGLT1 activity from 0 to 4-day post-confluence in IEC-18 cells
(376± 57.71). This phenomenon of increasing SGLT1 activity may be due to increasing cellular
maturation, cellular polarity and/or an increase in the number of transporters itself and is
comparable to what is seen in vivo during crypt to villus maturation (Coon et al., 2005).

Figure 10. Increase in Na-dependent glucose uptake as IEC-18 cells mature. Uptake was
performed in the presence and absence of phlorizin (1 mM) in reaction medium containing [3H]OMG tracer. Values are represented as means ± SEM, n=6 independent experiments. Values not
sharing common superscripted letters are significantly different at P < 0.001.
3.4.3. Na-K-ATPase activity levels during cell growth
As enterocytes mature, along with the appearance of BBM transporters, BLM Na-KATPase activity increases to provide the favorable Na gradient necessary to absorb nutrients.
Similar to the in vivo observation in rabbit intestine (S. Singh et al., 2015), Na-K-ATPase
activity, as determined by inorganic phosphate (Pi) release increased gradually in IEC-18
cellular homogenates from 0-4 days post-confluence (Figure 11A, 5.01±0.12 nanomole/mg
protein.min in 0-day, 5.74±0.47 in 1-day, 14.48±1.07 in 2-day, 14.58±0.90 in 3-day, 13.72±0.23
in 4-day). Since Na-K-ATPase is a membrane protein, plasma membrane fraction were prepared
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from IEC-18 cells, and in these preparations, Na-K-ATPase activity also increased gradually
from 0-day to 4-day (Figure 11B, 49.81±02.74 nanomole/mg protein.min in 0-day, 81.36±1.775
in 1-day, 86.53±1.617 in 2-day, 102.8±4.01 in 3- day, 115.6±3.58 in 4-day). Finally, since
radiolabeled rubidium (86Rb+) uptake is more a functional measure of Na-K-ATPase activity in
live cells, it was measured. 86Rb+ uptake also increased gradually from 0-day to 4-day (Figure
12, 649.2±6.95 nanomole/mg protein.min in 0-day, 958.6±32.52 in 1-day, 1285±22.28 in 2-day,
1335±39.27 in 3-day, 1565±8,17 in 4-day). Thus, these data indicate that as IEC-18 cells mature
from crypt-like at 0-day post-confluence to villus-like at 4-day post-confluence, Na-K-ATPase
activity increased comparable to in vivo crypt and villus cells.

Figure 11. Na-K-ATPase activity as measured by Pi release in IEC-18 cells. Na-K-ATPase
activity was measured in the presence or absence of ouabain (1 mM). The absolute Na-KATPase activity presented was calculated by subtracting Pi release in the presence of ouabain
from that in the absence of ouabain. A. Cellular homogenates. B. Plasma membrane
preparations. Values are represented as means
SEM, n=5. Values not sharing common
superscripted letters are significantly different at P < 0.01.
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Figure 12: Na-K-ATPase activity as measured by 86Rb+ uptake in IEC-18 cells. Values are
represented as means SEM, n=5. Values not sharing common superscripted letters are
significantly different at P < 0.01.
3.4.4. Kinetic Studies during cell growth
To determine the mechanism of the increase in Na-K-ATPase activity from 0-4 days
post-confluence, we performed 86Rb+ kinetics in IEC-18 cells. As the concentration of
extracellular Rb+ was increased, Rb+ uptake was stimulated and subsequently became saturated
in all conditions. Kinetic parameters showed that there was no significant change in Vmax among
the groups. However, there was a significant difference in Km from 0-4 days post-confluence
(Table 5). Affinity (1/Km) of Na-K-ATPase increased gradually as the cells matured from 0-4
days post-confluence as shown in Table 5.
Vmax
(picomole/mg protein*30 Sec)
Km
(mM)

0 Day

1 Day

2 Day

3 Day

4 Day

742.5±62

714±83.5

718±58.4

713±27.9

733±44.8

0.68±0.11a 0.61±0.15a 0.39±0.08b 0.37±0.04b 0.33±0.06b

Table 5: Kinetic parameters of Na-K-ATPase transporters in IEC-18 Cells. Uptake of 86Rb+
as a function of varying concentration of extracellular Rb+ (Rubidium chloride (RbCl)). As
extracellular Rb+ concentration was increased, uptake of 86Rb+ was stimulated and subsequently
became saturated in all groups. Kinetic parameters [maximal uptake (Vmax) and affinity (1/Km)]
were obtained after the analysis of data with GraphPad Prism software. Values are represented as
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mean
SEM, n=6. Values not sharing common superscripted letters are significantly different
at P < 0.01.
3.4.5. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance during cell growth
The α subunit primarily provides Na-K-ATPase functional activity whereas the β subunit
does not have pumping activity but contributes to proper transportation of the α subunit to the
plasma membrane to make the entire protein fully functional. Therefore, to determine whether
the change in Na-K-ATPase activity may be transcriptionally regulated, we performed qRTPCR. There was no significant difference in the relative expression of Na-K-ATPase α1 mRNA
(Figure 13A) between different groups (0-4 days). Similarly, the Na-K-ATPase β1 subunit
mRNA abundance (Figure 13B) was also not statistically different between the groups (0-4
days).

Figure 13. qRT-PCR analysis of IEC-18 cells on diﬀerent days post conﬂuence. Values are
relative to 0-day and normalized to β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values
are represented as mean
SEM, n=4.
3.4.6. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression during cell growth
Since mRNA levels of the Na-K-ATPase α1 and Na-K-ATPase β1 subunits do not
always correlate with protein expression, Western blot analysis of protein expression of the NaK-ATPase α1 and Na-K-ATPase β1 subunits were performed. Immunoreactive protein levels of
54

Na-K-ATPase α1 and Na-K-ATPase β1 subunits were determined in cellular homogenates and
plasma membrane fractions. Densitometric analysis of relative protein expression revealed that
the level of Na-K-ATPase α1 protein expression was not statistically different in IEC-18 cells
from 0-4 days post-confluence in cellular homogenates (Figure 14A) or plasma fractions (Figure
15A). Similarly, there was also no significant difference in Na-K-ATPase β1 subunit protein
expression among IEC-18 cells from 0-4 days post-confluence in cellular homogenates (Figure
14B) and plasma membrane fractions (Figure 15B). Protein expression of Na-K-ATPase α1 and
Na-K-ATPase β1 subunits correlates with mRNA expression of these subunits, respectively.
Further, these studies are consistent with kinetic parameters determined above. Therefore, the
expression of Na-K-ATPase α1 and Na-K-ATPase β1 subunits were unaltered in cellular
homogenates and plasma membrane fractions in IEC-18 cells during maturation. Thus, the
increase in Na-K-ATPase activity as IEC-18 cells mature from crypt-like to villus-like cells is
secondary to increased affinity of the protein which may be due to altered phosphorylation of the
α1 Na-K-ATPase subunit.
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Figure 14. Western blot analysis of diﬀerent post conﬂuence IEC-18 cells in cellular
homogenates. A. Representative blot of Na-K-ATPase α1, Na-K-ATPase β1 and internal control
β-actin. Densitometric quantitation of western blots. B. Na-K-ATPase α1 and C. Na-K-ATPase
β1. Values are relative to 0-day and normalized to β-actin. Values are represented as mean
SEM, n=4.

Figure 15. Western blot analysis of diﬀerent post conﬂuence IEC-18 cells in plasma
membrane fractions. A. Representative blots of Na-K-ATPase α1 and Na-K-ATPase β1.
Densitometric quantitation of western blots. B. Na-K-ATPase α1 and C. Na-K-ATPase β1. Equal
amount of proteins was loaded. Values are relative to 0-day and represented as mean
SEM,
n=4.
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3.4.7 Protein phosphorylation of Na-K-ATPase α1 subunit during cell growth
To examine whether changes in Na-K-ATPase activity during different days of post
confluence is due to phosphorylation of Na-K-ATPase α1 subunit, thus affecting its affinity,
immunoprecipitation studies were performed. Na-K-ATPase α1 subunit was immunoprecipitated
from the plasma membrane on different days of post-confluence and probed with antibodies
specific for phosphorylated amino acids (serine, threonine, and tyrosine). As shown in the
representative blot and densitometric analysis in Figure 16, immunoprecipitated Na-K-ATPase
α1 subunit from different days of post confluence had a gradual increase in the levels of
phosphorylated tyrosine (Figure 16B; 100% in 0-day and 170±21.41 in 4-day post-confluence).
Similarly, phosphorylated serine levels also increased (Figure 16C; 100% in 0-day and 179±5.08
in 4-day post confluence). However, phosphorylated threonine levels remained unchanged. To
determine which specific residues might be the target of phosphorylation during maturation,
proteins extracted from different days were probed with anti-p-Na-K-ATPase α1-Ser23 and antip-Na-K-ATPase α1-Ser16 antibodies, the targets of which have been previously implicated in
alterations in Na-K-ATPase activity. As shown in the representative blot and densitometric
analysis in Figure 17, p-Na-K-ATPase α1-Ser23 had a gradual increase (100% in 0-day and
241.3±5.5 in 4-day post-confluence) in its phosphorylation levels during IEC-18 cell growth.
These data confirmed that a change in Na-K-ATPase activity during cell growth is likely due to
changes in phosphorylation of Na-K-ATPase α1 subunit, specifically at serine and tyrosine
amino acid residues and possibly involving p-Na-K-ATPase α1-Ser23 residue.
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Figure 16. Western blot analysis of phosphorylation levels of Na-K-ATPase α1 during
diﬀerent days post conﬂuence IEC-18 cells in plasma membrane fractions. A. Representative
blot of p-tyrosine, p-serine, p-threonine and Na-K-ATPase α1 after immunoprecipitation with
Na-K-ATPase α1. Densitometric quantitation of western blots. B. p-tyrosine. C. p-Serine. D. pThreonine. Values are relative to 0-day and normalized to Na-K-ATPase α1. Values are
represented as mean
SEM, n=4. Values not sharing common superscripted letters are
significantly different at P < 0.05.
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Figure 17. Western blot analysis of Na-K-ATPase α1-Ser23 at diﬀerent days post conﬂuence
IEC-18 cells in plasma membrane fractions. A. Representative blot of experiment done in
triplicate. B. Densitometric analysis of western blots. Values are relative to 0-day and normalized
to Na-K-ATPase α1. Values are represented as mean
SEM, n=3. Values not sharing common
superscripted letters are significantly different at P < 0.01.
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3.5. DISCUSSION
Villus and crypt cells have been extensively investigated concerning absorption
mechanisms of Na-dependent nutrient co-transporters at the level of the co-transporters in the
BBM. At the cellular level, all of these Na-dependent co-transport processes may be regulated
secondary to alterations in BLM Na-K-ATPase since it provides the necessary Na gradient for
these secondary active transport processes. However, the Na-K-ATPase located in the BLM that
drives these nutrient transporters has not been previously studied concerning its mechanism of
adaption to support the increasing nutritional absorptive capacity during the growth and
maturation of intestinal epithelial cells. Therefore, the present study was undertaken to
understand the mechanism of Na-K-ATPase regulation during the maturation of intestinal
epithelial cells from the crypt to villus.
During the maturation of intestinal cells from the crypt to villus, significant
morphological and physiological changes occur. Morphological changes include changes in
composition and membrane surface area. Along with these changes, physiologically mature cells
acquire more transporters and therefore, their capacity to absorb nutrients increases. A study of
the crypt-villus axis of piglets has shown that there is upregulation of proteins associated with
glycolysis/gluconeogenesis, fatty acid metabolism, amino acid metabolism, and the citrate cycle
as cells mature from crypt to villus (Yang, Wang, Xiong, & Yin, 2016). Additionally, it has been
reported that alkaline phosphatase (ALP), aminopeptidase, sucrose, lactase, and Na-K-ATPase
activities increased along the crypt-villus axis in jejunum and ileum of neonatal pigs (Fan, Stoll,
Jiang, & Burrin, 2001). Similar to these results, our study has shown that there is an increase in
ALP and SGLT1 activities as IEC-18 cells mature from crypt-like to villus-like cells in vitro.
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There are conflicting reports in the literature addressing the levels of Na-K-ATPase
activity during the maturation of cells (Blostein, Drapeau, Benderoff, & Weigensberg, 1983;
Brugnara & de Franceschi, 1993; Furukawa, Bilezikian, & Loeb, 1981). For example, in one
study a reduction in activity was found to be due to the shedding of Na-K-ATPase into exosomes
or due to degradation (Mairbaurl, Schulz, & Hoffman, 2000). This study has shown that there is
an increase in Na-K-ATPase activity as IEC-18 cells mature from crypt-like to villus-like cells.
The increase or decrease in activity may be the result of various mechanisms: firstly, by
increasing or decreasing the subunits α and β respectively (Erichsen, Zuo, Curtis, Rarey, &
Hultcrantz, 1996; Vasarhelyi et al., 2000; Wang & Celsi, 1993; Wang, Yasui, & Celsi, 1994).
The increased Na-K-ATPase activity could be, therefore, due to an increase in these subunits by
increased mRNA and protein synthesis. Secondly, the translocation of α and β subunits from the
cytoplasm to the plasma membrane (Bertorello & Katz, 1993; McDonough & Farley, 1993;
Pedemont & Bertorello, 2001). The increased translocation of α and β subunit to the plasma
membrane could, therefore, increase the Na-K-ATPase activity. Among different isoforms of α
and β subunits, α1 and β1 isoforms are expressed ubiquitously and are observed to perform a
housekeeping role in most epithelial cell types, including intestinal epithelial cells (Rajasekaran,
Barwe, & Rajasekaran, 2005; Saha et al., 2015). During the development and maturation of
erythrocytes, Na-K-ATPase enzyme activities were found to decrease with maturation,
correlating with a decrease in the α1 subunit (Rosen & Sigstrom, 1978). Similarly, in conjunction
with Na-K-ATPase activity, the α1 isoform also increases during the maturation of cochlea
(Curtis, ten Cate, & Rarey, 1993). However, in the present study, we did not find any significant
changes in mRNA expression of the α1 isoform or its protein levels though there was an increase
in Na-K-ATPase activity.
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For Na-K-ATPase to be fully functional as a transporting unit in the plasma membrane,
assembly of the β subunit with the α subunit is essential. The association of the β subunit with
the α subunit is required for maturation, membrane insertion and transport activity of the α
subunit (Tokhtaeva, Clifford, Kaplan, Sachs, & Vagin, 2012). Na-K-ATPase α and β
heterodimer are selective in their subunit isoform association, where the α1 subunit mostly
assembles with the β1 isoform (Tokhtaeva et al., 2012). Although there was elevated Na-KATPase activity, the expression level of β1 mRNA and protein in cellular homogenates remain
unchanged during maturation. Therefore, the level of Na-K-ATPase α1 and β1 mRNA and
protein in cellular homogenates confirmed that Na-K-ATPase is regulated post-translationally.
Correspondingly, there was also no alteration in Na-K-ATPase α1 and β1 expression in the
plasma membrane. Therefore, the unaltered level of Na-K-ATPase α1 and β1 protein expression
in both cellular homogenate and plasma membrane also indicate that increased Na-K-ATPase
activity during maturation is not likely due to altered intracellular trafficking.
The increase in Na-K-ATPase activity could be due to a change in the affinity of the NaK-ATPase to Na+, K+ and ATP (Faleiros, Garcon, Lucena, McNamara, & Leone, 2018;
Kristensen & Juel, 2010). In the present study, there was an increase in the affinity for K+ of NaK-ATPase during cell maturation. This change in affinity may be due to the level of the
phosphorylation of the protein. Considerable evidence indicates that the Na-K-ATPase activity is
regulated by phosphorylation of the Na-K-ATPase α1 subunit on serine, threonine (Beguin et al.,
1994; Bertorello et al., 1991; Chibalin, Vasilets, Hennekes, Pralong, & Geering, 1992; Fisone et
al., 1994) and tyrosine residues (El-Beialy et al., 2010; Feraille et al., 1999). It has been reported
that there are at least 21 phosphorylation sites in rat Na-K-ATPase α1 (Soltoff, Asara, & Hedden,
2010), including 6 tyrosine, 1 threonine, and 14 serine phosphorylation sites. Protein kinases A
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and C (PKA, PKC) have been reported to phosphorylate the α subunit specifically on serine and
threonine residues (Beguin et al., 1994; Bertorello et al., 1991; Chibalin et al., 1992; Fisone et
al., 1994) whereas various tyrosine kinases phosphorylate at tyrosine residues, thus, regulating
Na-K-ATPase activity (El-Beialy et al., 2010; Feraille et al., 1999). Multiple studies have
reported that the phosphorylation of the Na-K-ATPase α1 subunit on tyrosine residues causes
different responses on Na-K-ATPase activity (Al-Khalili et al., 2004; El-Beialy et al., 2010;
Feraille et al., 1999). While some reports have demonstrated that increased tyrosine
phosphorylation of Na-K-ATPase α1 in rat kidney tubules (Feraille et al., 1999) and human
skeletal muscle cells (Al-Khalili et al., 2004) increases the activity of the Na-K-ATPase, others
have reported that increased tyrosine phosphorylation of Na-K-ATPase α1 in human and pig
renal cells reduces the activity of Na-K-ATPase (El-Beialy et al., 2010). This differential
regulation of Na-K-ATPase pump activity by tyrosine phosphorylation might be due to
phosphorylation at different residues or due to the differences in both tissue and species. Our
study demonstrates that there is an increase in Na-K-ATPase α1 tyrosine phosphorylation in
conjunction with its increase in activity as cells mature. The different results suggest that
depending on the tissue studied, and the experimental conditions, phosphorylation of serine and
tyrosine leads to either activation or inhibition of Na-K-ATPase (Pedemont & Bertorello, 2001).
However, in the present study, we observed that there was an increase in serine and tyrosine
phosphorylation whereas there was no change in threonine phosphorylation as cells mature.
Various studies have demonstrated that Ser16 and Ser23 on the N terminus of Na-KATPase α1 are PKC phosphorylation sites (Beguin et al., 1994; Chibalin et al., 1992). Ser16 is
well conserved among mammalian α1 isoforms but is weakly phosphorylated (Pierre, Duran,
Carr, & Pressley, 2002), whereas Na-K-ATPase α1-Ser23 is the most extensively studied residue.
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Furthermore, Na-K-ATPase α1-Ser23 phosphorylation either increases or decreases the activity of
Na-K-ATPase activity depending on the tissue type and experimental conditions. However, in
the present study, Na-K-ATPase α1-Ser23 phosphorylation increases as cells mature with
increases in Na-K-ATPase activity.
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3.6. CONCLUSION
In summary, this study determined that as the intestinal epithelial cells mature from
secretory crypt-like (0-day) to absorptive villus-like (4-day post confluence) cells, the Na-KATPase activity also increases to support the increasing absorptive capacity of the enterocytes.
Na-K-ATPase activity increased secondary to increases in affinity (1/Km) rather than an increase
in transporter numbers as cells matured from crypt to villus. Specifically, altered affinity is likely
due to changes in phosphorylation of α1 subunit of Na-K-ATPase.
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4.1. ABSTRACT
In the mammalian small intestinal epithelial cells, Na-K-ATPase provides a favorable
transcellular Na gradient required for the functioning of Na-dependent nutrient transporters, thus
enabling the assimilation of nutrients. Glutamine, the primary metabolite for enterocytes, is
absorbed via Na-glutamine co-transporter (SN2) in intestinal crypt cells. SN2 is stimulated
during chronic intestinal inflammation secondary at least in part to the stimulation of Na-KATPase during chronic ileitis. Immune-inflammatory mediator Leukotriene D4 (LTD4) is known
to be elevated in the mucosa during chronic enteritis, but how it may regulate Na-K-ATPase is
not known. Therefore, this study aims to determine the effect of LTD4 on Na-K-ATPase in
intestinal epithelial cells and define its mechanism of action. In an in vitro model of rat intestinal
epithelial cells (IEC-18 cells), grown to confluence, Na-K-ATPase activity was significantly
stimulated by LTD4 (1 μm) as measured by 86Rb+ uptake in cells and inorganic phosphate (Pi)
release in the plasma membrane. Since LTD4 mediates its action via calcium-dependent protein
kinase C (PKC), calcium levels were measured and were shown to be increased by LTD4.
Phorbol 12-Myristate 13-Acetate (PMA), an activator of PKC, mediated stimulation of Na-KATPase similar to LTD4, while BAPTA-AM (calcium chelator) and Calphostin-C (PKC
inhibitor) reversed the stimulation of Na-K-ATPase activity by LTD4. LTD4 caused a significant
increase in mRNA and plasma membrane protein expression of Na-K-ATPase α1, and β1
subunits which were prevented by Calphostin-C. These studies demonstrate that LTD4
stimulates Na-K-ATPase. The mechanism of stimulation is secondary to the transcriptional
increase of Na-K-ATPase α1 and β1 subunits in the chronically inflamed intestine. Therefore,
LTD4 mediates this transcriptional stimulation of Na-K-ATPase via Ca2+-activated PKC
pathway in intestinal epithelial cells during chronic intestinal inflammation.
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4.2. INTRODUCTION
The primary function of the mammalian small intestine is an absorption of nutrients vital
for the survival of the organism. The process of nutrient absorption occurs through a monolayer
of epithelial cells (innermost layer of the mucosa), called enterocytes, present in the small
intestine. These enterocytes are further divided into immature enterocytes (crypt cells) and
mature enterocytes (villus cells). In the mammalian small intestine, the villus cells are generally
considered to be absorptive thus possessing virtually all nutrient absorptive transport pathways.
In contrast, crypt cells are typically considered to be secretory and not known to have any
nutrient absorptive pathways except for Na-glutamine co-transport, SN2 in the brush border
membrane (BBM).
Crypt cell BBM SN2 requires a favorable Na-gradient which is established by Na-KATPase, an integral transmembrane protein located on the basolateral membrane (BLM) of these
cells. In an animal model of chronic intestinal inflammation, resembling human inflammatory
bowel disease (IBD), it has been demonstrated that SN2 is stimulated in crypt cells, at least in
part secondary to the stimulation of Na-K-ATPase (Arthur et al., 2012; Saha et al., 2012).
Further, it has been shown that the immune inflammatory mediator, LTD4, is increased in the
mucosa during chronic intestinal inflammation. Finally, it has also been shown that inhibition of
the formation of leukotrienes in this animal model of IBD, reverses the stimulation of Na-KATPase and subsequently SN2 in crypt cells (S. Singh et al., 2018). However, it is unknown how
LTD4 may stimulate Na-K-ATPase in crypt cells during chronic intestinal inflammation.
It is well established that various physiological and pathophysiological conditions alter
Na-K-ATPase through numerous mechanisms. It has been reported that there is a reduction of
Na-K-ATPase activity in several diseases such as chronic neurodegenerative disorder (Chauhan,
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Lee, & Siegel, 1997), cardiovascular (Ziegelhoffer et al., 2000), or renal disease (Rose & Valdes,
1994). Similarly, malabsorption of a variety of nutrients in IBD is partly due to altered Na-KATPase activity (Arthur et al., 2012; Coon et al., 2010; Coon et al., 2005; Saha et al., 2012;
Sundaram et al., 2007). For example, in the IBD intestine it has been shown that in villus cells,
BBM Na-glucose co-transport (SGLT1), Na-alanine co-transport (NAcT), Na-bile acid
cotransporter (ASBT) and Na-glutamine co-transport (B0AT1) are all inhibited. All of these cotransporters are altered at the level of the co-transporter in the BBM in the IBD intestine. But at
the cellular level, the down-regulation of these co-transporters is due to the down-regulation of
BLM Na-K-ATPase leading to the loss of the intracellular Na+ gradient. However, interestingly
only in crypt cells, Na-K-ATPase activity was upregulated during chronic intestinal
inflammation with concurrent stimulation of BBM Na-glutamine co-transporter SN2 (Saha et al.,
2012). This new observation is made all the more critical because SN2 is the sole nutrient
absorptive pathway in crypt cells in health and disease. Further, Na-K-ATPase activity and
subsequently SN2 activity was reversed to normal levels by treatment with a corticosteroid,
methylprednisolone (Saha et al., 2012; S. Singh et al., 2018; S. Singh et al., 2015). These studies
establish that immune inflammatory mediators are responsible for altered BLM Na-K-ATPase as
well as BBM SN2 in crypt cells during chronic intestinal inflammation.
Arachidonic acid metabolites (AAMs) are prominent inflammatory mediators present in
the mucosa of intestinal tissue from patients with IBD (Romero et al., 2008) and ulcerative
colitis (Carty, Nickols, Feakins, & Rampton, 2002). AAMs, specifically prostaglandin E2
(PGE2) and leukotriene D4 (LTD4) have been associated with the pathogenesis of several
diseases including rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, and IBD. It has
been reported that LTD4 has also been associated with inflammatory processes (Ford-
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Hutchinson, Bray, Doig, Shipley, & Smith, 1980) as well as intestinal secretion (Musch et al.,
1982). LTD4 has also been involved in the stimulation of SN2 and Na-K-ATPase in IEC-18 cells
(S. Singh & Sundaram, 2015). However, the molecular mechanisms responsible for the
stimulation of Na-K-ATPase by LTD4 in crypt cells during IBD have not been determined.
Na-K-ATPase is dynamically regulated to change its activity according to its
physiological requirement. This holoenzyme is constituted of various subunits: alpha (α), beta
(β) and gamma (g) subunits. Of these subunits, two dissimilar subunits, α and β, are required for
the proper assembly and functioning of Na-K-ATPase (Li & Langhans, 2015; McDonough &
Farley, 1993; Mercer, 1993). However, the g subunit is expressed in specific tissues and is
optional for the functional activity of Na-K-ATPase (Kaplan, 2002). Of these subunits, the α
subunit has the catalytic function: exchange of 2K+ inside the cells to 3Na+ outside the cells as
well as cleaving of ATP (Pressley, Allen, Clarke, Odebunmi, & Higham, 1996). However, the β
subunit facilitates maturation of the α subunit by the formation of α/β heterodimer and
transporting this enzyme to the plasma membrane (Geering, 1991). Thus, both of these subunits
are required for the efficient functioning of Na-K-ATPase hence generating optimum sodium
gradient inside the cell. This sodium gradient actuates secondary transport processes on BBM,
specifically Na-nutrient co-transporter, thus enabling intestinal epithelial cells to absorb nutrients
efficiently. At least four isoforms of the α subunit (α1, α2, α3, and α4) and three isoforms of the
β subunit (β1, β2, and β3) are reported to date. These isoforms are expressed in a tissue-specific
manner (Blanco et al., 1999; Kaplan, 2002; Mercer, 1993). The combination of different
isoforms of α and β subunits make up a series of Na-K-ATPase isoenzymes (Blanco & Mercer,
1998a). Each isoenzyme has different functional properties and is expressed differentially in a
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tissue- and cell-specific manner (Jewell et al., 1992). Of these isoforms, α1 and β1 are
ubiquitously present in epithelial cells and are also present in the mucosa of the intestine.
Na-K-ATPase activity is tailored to change according to the physiological requirements
of the cell. There are several mechanisms that regulate Na-K-ATPase activity-for example, the
availability of the substrates (Na+, K+, and ATP). Also, the amount of the enzyme at the plasma
membrane can be modified by changes in the rate of synthesis or degradation of the individual
Na pump polypeptide and movement of the pump from the cytoplasm to the plasma membrane
by exo/endocytotic vesicular transport (Blanco et al., 1998). Apart from these mechanisms, NaK-ATPase activity at the cell surface is directly regulated by phosphorylation and
dephosphorylation by protein kinases and protein phosphatases respectively (Bertorello & Katz,
1993; Ewart & Klip, 1995; McDonough & Farley, 1993). Moreover, phosphorylation of
transcription factors associated with Na-K-ATPase α and β subunits also changes the expression
and activity of Na-K-ATPase (Li & Langhans, 2015; Serhan & Kreydiyyeh, 2011).
Given this background, very little research has been conducted regarding the effect of
LTD4 on Na-K-ATPase in crypt cells, although Na-K-ATPase is vital for the absorption of
glutamine in crypt cells. Thus, this study aims to determine the molecular mechanism of
stimulation of Na-K-ATPase by LTD4 in crypt cells during chronic intestinal inflammation.
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4.3. MATERIALS AND METHODS
4.3.1. Reagents
All reagents were purchased from Cayman chemicals (Ann Arbor, Michigan, USA):
Leukotrine D4 (LTD4) (Cat # 20310), REV 5901 (Cat #70600), Calphostin-C (Cat #15383),
REV 5901 (Cat #70600), Phorbol 12-myristate 13-acetate (PMA, Cat# 10008014), BAPTA-AM
(Cat# 15551), Amlodipine (Cat#14838) used in the experiments. All reagents were dissolved in
DMSO except LTD4, which was dissolved in ethanol to make the stock solutions. The final
working concentration of the solutions contained less than 0.5% of DMSO or ethanol. Toxicity
of all the drugs was assessed, and the safe dose was used for further experiments (Supplementary
Figures- Figure 39).
4.3.2. Cell culture
The rat small intestine cells (IEC-18) (American Type Culture Collection), between
passages 5 and 20, were used for all of the experiments. Cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100
U/l human insulin, 0.25 mM b-hydroxybutyric acid, and 100 units/ml penicillin and
streptomycin. These cells were cultured in a humidified atmosphere of 10% CO2 at 37°C. Cells
were fed with fresh DMEM every other day.
4.3.3. Cell viability assay
For assessing the cell viability, the MTT (3-(4,5-dimethylthaizol-2-yl)-2,5diphenlytetrazolium bromide) assay was performed. Vybrant MTT cell proliferation kit (cat#V13154) was purchased from Thermofisher Scientific. To perform the MTT assay, cells were
seeded with equal number of cells in 96 well plate and cultured until confluent, then treated with
test chemicals for desired time. Then medium was then removed from the wells and replaced
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with 100 µl of fresh medium. After that, 10 µl of 12 mM MTT solution (prepared in PBS) was
added and incubated at 37°C for 2 hours. The whole medium was aspirated and replaced with
100 µl of SDS-HCL solution to each well and mixed thoroughly. The cells were incubated in
SDS-HCL solution overnight (~12 hrs) at 37°C. Then the solution was again mixed, and
absorbance was read on the spectrophotometer at 570nm. Trypan blue exclusion assay was also
performed to measure the cell viability.
4.3.4. Crude plasma membrane preparation
Plasma membrane (crude) was isolated from cells according to the method of
Havrankova et al. (Havrankova et al., 1978). Subsequently, cells were mixed with 2.5-fold
volume of 0.001 M NaHCO3 and homogenized 3 times (10 seconds each) with homogenizer
(IKA, Cat# 823707, T25 S1c). These homogenized cells were centrifuged at 600 x g for 30 min.
The resultant supernatant was centrifuged for 30 min at 20,000 x g. The membrane was washed
twice with 0.001 M NaHCO3. The final pellet was resuspended in 0.04 M Tris-HCl buffer (pH
7.4) containing 0.1% BSA. All procedures were carried out at 4oC.
4.3.5. Na-K-ATPase activity assay
Na-K-ATPase activity was measured as Pi liberated (Forbush, 1983) in plasma
membrane fractions from cells. Enzyme-specific activity was expressed as nanomoles of Pi
released per milligram protein per minute.
4.3.6. RNA isolation and qRT-PCR
RNA was isolated from different experimental groups by using RNeasy mini kit obtained
from Qiagen. Real-time quantitative PCR (qRT-PCR) was performed using isolated total RNA
by a two-step method. First, total RNA was used to synthesize cDNA using SuperScript III
(Invitrogen, Life Technologies) and an equal mixture of oligo (dT) primer and random hexamers.
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Second, newly synthesized cDNA was used as template to perform real-time PCR using TaqMan
Universal PCR master mix from Applied Biosystems (Foster city, CA) according to
manufacturer’s protocol. Rat specific Na-K-ATPase α1- and β1-specific primers and probe were
used for the qRT-PCR studies. Rat specific β-actin primer and probe was used as housekeeping
gene to normalize the expression of samples.
4.3.7. 86Rb+ uptake for Na-K-ATPase activity
IEC-18 cells uptake studies were grown in 24 well transwell inserts (Corning Transwell #
29442, insert size 24 mm, pore size 0.4 µ). IEC-18 cells were plated with equal number of cells.
Uptake studies for Na-K-ATPase were done using radioactive Rubidium (86Rb+, PerkinElmer).
Cells were incubated for 1 hr in serum free DMEM (SFM). The cells were subsequently washed
with SFM and incubated for 10 min at 37°C in SFM containing 20μM monensin on both sides of
the membrane. Then cells were washed with SFM. Na-K-ATPase uptake studies were then
performed by incubating cells for 15 min with reaction mixture [SFM and 86Rb+ (~1 μCi/well)]
on the basolateral side of the membrane in presence and absence of ouabain (1 mM). The
reaction was stopped by addition of ice-cold MgCl2, subsequently washed three times with
MgCl2, and the cells were lysed with 800 μl of 1N NaOH and incubation for 30 min at 70°C,
which was then mixed with 5 ml of Ecoscint A (National diagnostics). The vials were kept in
darkness overnight and radioactivity retained by the cells was determined in a Beckman Coulter
6500 scintillation counter.
4.3.8. Calcium measurement
Calcium measurement was performed using the Fluo-8 calcium flux assay kit (Abcam,
cat# ab112129). Cells were seeded with equal number of cells in 96 well plate and cultured until
confluent, then treated with test chemicals for desired time. Subsequently, the supernatant was
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removed and replaced with 100 μl Fluo-8 dye-loading solution per well and incubated for 30 min
at room temperature. Next, the fluorescence intensity was measured at Ex/Em of 490/525 nm
using a fluorescence plate reader (Spectramax i3x, Molecular Devices).
4.3.9. Immunocytochemistry (ICC) staining
IEC-18 cells were grown on a coverslip until 4-day post-confluence. Cells were treated
respectively as mentioned before. Following the treatment for 24 hours, cells were fixed with
100% methanol (chilled at -20°C) at room temperature for 5 min. After cells were permeabilized
with PBST (PBS + 0.5% Tween 20) for 10 min, cells were blocked with 3% BSA in PBST for
30 min. Then the cells were incubated for an hour at room temperature with primary antibody
Zonula occludens (ZO-1) (Anti-Rabbit; Invitrogen, cat# 40-2200), Na-K-ATPase (Anti-mouse;
Millipore, cat# 05-369). The secondary antibody (Alexa Fluor; Invitrogen) was added, and the
cells were incubated at 37°C for 1h. Cells were mounted with DAPI mounting medium and
sealed with nail polish to prevent cells from drying. An EVOS microscope was used to capture
images, and ImageJ was used for analysis.
4.3.10. Western blot analysis
Western blot analysis was performed on plasma membrane fractions prepared from
different samples as described above. Equal amounts of protein were denatured in sample buffer
(10 mM Tris-HCl pH 7,12% glycerol, 2% SDS, 0.01% bromophenol blue, and freshly added
1mM Dithiothreitol) and separated by electrophoresis on an 8% polyacrylamide gel. Proteins on
the gel were transferred to a polyvinylidene fluoride membrane which was blocked with 5% milk
or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1% Tween-20 and then incubated
with primary antibody against Na-K-ATPase α1 (Millipore, cat# 05-369) or Na-K-ATPase β1
(Abcam, cat# ab2873) overnight at 4°C. Membranes were washed three times each with TBS and
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TBST, followed by incubation with secondary antibody for 1 hr. Membranes were washed again
three times each with TBS and TBST. An ECL western blotting detection reagent (GE healthcare
Bio-Sciences, Piscataway, NJ) was used to detect the immobilized protein. The
chemiluminescence was detected using FluorChemM instrument (Alpha Innotech, San Leandro,
CA) and analyzed with its software. Ezrin antibody (Abcam, cat#ab4069) was used to normalize
the expression levels of proteins in plasma membrane.
4.3.11. Protein determination
Total protein was measured by the Lowry method using the Bio-Rad DCTM Protein
Assay Kit (Hercules, CA, USA). Different concentrations of BSA were used as a standard.
Samples were diluted to 200 µl with water. The diluted sample was mixed with 250 µl of DC
Protein Assay reagent A (cat# 500-0113) and incubated for 2 minutes. Subsequently, the sample
was incubated for another 15 minutes after the addition of 2 ml DC Protein Assay reagent B
(cat# 500-0114). Finally, the sample was read at OD750nm using a spectrophotometer.
4.3.12. Statistical analysis
All groups presented have at least n=4 per group, repeated with different passages. The
values are presented as mean ± SEM, and p-values of <0.05 were taken to indicate statistical
significance. All of the data were analyzed using t- test, one-way or two-way analysis of variance
(ANOVA) using Graphpad prism software (San Diego, CA).
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4.4. RESULTS
4.4.1. Stimulation of Na-K-ATPase by LTD4
It has been shown that Na-K-ATPase activity in crypt cells, as well as LTD4 in the
mucosa is elevated in the chronically inflamed rabbit intestine (S. Singh et al., 2018). IEC-18
cells grown till confluence, at 0-day post confluence physiologically behave like crypt cells (e.g.,
has SN2 but not SGLT1 or NHE3). Therefore, in order to determine whether the LTD4 is
responsible for the stimulation of Na-K-ATPase, IEC-18 cells were treated with various
concentrations of LTD4 and the activity of Na-K-ATPase was measured by 86Rb+ uptake. Our
observations showed that Na-K-ATPase was significantly stimulated at 1µm of LTD4
(674.2±45.19 picomole/mg protein/min) compared to control (334.8±73.8). However, lower
amounts of LTD4 did not show any stimulation (0.1µm-399.4±59.46, 0.5µm-380.3±42.93p) and
higher amounts of LTD4 than 1 µm also did not show any additional stimulation of Na-KATPase (Figure 18A) The stimulation of Na-K-ATPase activity in plasma membrane by 1µm of
LTD4 was further corroborated with Na-K-ATPase assay Pi release (0µm-5.96±0.66, 1µm10.96±0.45 nanomole/mg protein/min; Figure 18B).

Figure 18. Eﬀect of LTD4 exposure for 24 hours on Na-K-ATPase activity in IEC-18 cells.
A. Measurement of Na-K-ATPase activity by 86Rb+ uptake (n=6). B. Measurement of Na-K77

ATPase activity by Pi release in plasma membrane (n=4). Values are represented as means ±
SEM. **, P < 0.01 vs 0 µM or control.
4.4.2. Effect of LTD4 exposure on cell viability
To ensure that LTD4 did not negatively affect the viability of IEC-18 cells, MTT and
trypan blue assays were performed. Cell viability was not significantly affected by LTD4 (Figure
19A) below 2 µm, thus for all experiments, a concentration of 1 µm was subsequently used. This
was also validated with the trypan blue exclusion assay (Figure 19B).

Figure 19. Eﬀect of LTD4 exposure for 24 hours on cell viability. A. Measurement of cell
Viability by MTT assay. B. Measurement of cell viability by trypan blue assay. Values are
represented as means ± SEM, n=6. *, P < 0.05 vs 0 µM.
4.4.3. Leukotriene receptor antagonist inhibited LTD4 effect on Na-K-ATPase
To determine whether the effect of LTD4 is mediated through its receptor, the effect of
the LTD4 receptor antagonist, REV5901, was studied in IEC-18 cells. REV5901 is a competitive
antagonist of peptidoleukotrienes and specifically blocks both receptors cysteinyl leukotriene
receptors 1 and 2, CysLT1 and CysLT2 (Van Inwegen et al., 1987). It is known that IEC-18 cells
have LTD4 receptors (CysLT1 and CysLT2) (Talukder et al., 2008) and these receptors are
inhibited by the specific LTD4 receptor inhibitor REV5901 (5 uM) (Talukder et al., 2008). After
the pretreatment with REV5901, cells were treated with or without LTD4 for 24 hours, followed
78

by a rubidium uptake assay. While LTD4 alone produced a significant increase in rubidium
uptake, neither REV5901 alone nor REV5901+LTD4 affected rubidium uptake compared to the
control, as seen in Figure 20. These data indicate that the stimulatory effect of LTD4 is mediated
through its receptor activation in IEC-18 cells.

Figure 20. Eﬀect of LTD4 receptor inhibitor REV5901 (5 µM) on Na-K-ATPase activity in
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as
means ± SEM, n=6. **, P < 0.01; n.s., not significant.
4.4.4. Effect of LTD4 on intracellular calcium [Ca2+]i
Ca2+ is a second messenger and plays an essential role in signal transduction by either
activation through ion channels or by G-protein coupled receptors (Clapham, 2007). This cation
is vital for many physiological processes, including muscle contraction, neuronal excitability,
cellular motility, cell growth and apoptosis (Berridge, Lipp, & Bootman, 2000; Rash, Ackman,
& Rakic, 2016). Therefore, we looked for the effect of LTD4 on [Ca2+]i levels. Calcium channels
were blocked with amlodipine in IEC-18 cells and then cells treated with LTD4. The [Ca2+]i
levels increased in cells treated with LTD4 as shown in Figure 21. Intracellular Ca2+ increased
almost 2-fold within 5 minutes and peaked at 10 minutes (~ 3-fold) with LTD4. Levels reduced
gradually at later time points (30 minutes: ~2.3 fold, 60 minutes: ~1.8 fold, 180 minutes: ~1.3
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fold) but were still significantly higher than control. These data indicate that LTD4 increases
intracellular calcium.

Figure 21. Level of calcium at diﬀerent time points during LTD4 treatment. Measurement of
Ca2+ by Fluo-8 calcium flux assay. Values are relative to 1 min control and are represented as
means ± SEM, n=8. *, P< 0.05, **, P< 0.01 and ***, P<0.001 vs Control. Control and
Amlodipine (AML, calcium channel blocker) did not change significantly at different time
points.
4.4.5. Effect of calcium chelator on Na-K-ATPase activity in IEC-18 cells
Since LTD4 treatment elevated the Ca2+ level as shown in Figure 21, to determine
whether elevated intracellular Ca2+ is responsible for the stimulation of Na-K-ATPase, we used
the Bapta-AM. IEC-18 cells were pretreated with calcium chelator (1 µM) Bapta-AM followed
by measuring 86Rb+ uptake. Na-K-ATPase was found to be stimulated with LTD4 whereas
Batpa-AM treatment inhibited LTD4 mediated stimulation of Na-K-ATPase as shown in Figure
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22 (Control-381.6±50.54, LTD4-726.3±92.26, Bapta-AM-344±25.6, Bapta-AM+ LTD4326.5±46.8 picomole/mg protein/min). Bapta-AM alone had no effect (Figure 22).

Figure 22. Eﬀect of calcium chelator BAPTA-AM (1µM) on Na-K-ATPase activity in IEC18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as
means ± SEM, n=6. **, P < 0.01; n.s., not significant.
4.4.6. Effect of inhibition and activation of the PKC pathway on Na-K-ATPase activity in
IEC-18 cells
Previous studies have shown that PKC phosphorylates Na-K-ATPase subunits which
subsequently affects the activity of Na-K-ATPase (Galuska et al., 2011). To see whether PKC
mediates the LTD4 effect, the cells were pretreated with 0.1 µM calphostin-C (PKC inhibitor)
for an hour. After pretreatment, cells were treated with LTD4 for 24 hours, subsequently
followed by 86Rb+ uptake. Pretreatment with calphostin inhibited the LTD4-mediated stimulation
of Na-K-ATPase (Control-317.3±42.8, LTD4-710.3±61.17, Cal-C-400.8±30.14, Cal-C+ LTD4452±28.31 picomole/mg protein/min; Figure 23A). Similarly, the PKC activator PMA also
stimulated Na-K-ATPase comparable to LTD4 (Control-360.9±53.12, LTD4-636.9±65.51,
PMA-659.3±39.74; Figure 23B). These data indicate that PKC mediates LTD4 stimulation of
Na-K-ATPase in IEC-18 cells.
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Figure 23. Eﬀect of PKC inhibitor and activator on Na-K-ATPase activity in IEC-18 cells.
A. PKC inhibitor calphostin-C (0.1 µM). B. PKC activator PMA (1 µM). Measurement of Na-KATPase activity by 86Rb+ uptake. Values are represented as means ± SEM, n=6. **, P < 0.01 vs
Control; n.s., not significant.
4.4.7. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance during LTD4
treatment
Na-K-ATPase functional activity is primarily due to its α subunit whereas the β subunit
does not have pumping activity but provides proper transportation of the α subunit to plasma
membrane making it fully functional. Therefore, to determine whether the change in Na-KATPase activity is transcriptionally regulated, we performed qRT-PCR. There was a significant
increase in mRNA level of Na-K-ATPase α1 and Na-K-ATPase β1 subunits when exposed with
LTD4 by 160% and 180% respectively (Figure 24A and B). However, the Na-K-ATPase α1 and
Na-K-ATPase β1 subunits mRNA level remain unaltered compared to control when cells were
treated with Cal-C+ LTD4 (Figure 24A and B). This data indicated that Na-K-ATPase α1 and
Na-K-ATPase β1 subunits were transcriptionally regulated when treated with LTD4.
Additionally, the Na-K-ATPase α1 and Na-K-ATPase β1 subunits mRNA abundance returned
back to control levels when treated with Cal-C+LTD4, state that PKC play an important role in
LTD4 mediated regulation of Na-K-ATPase.
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Figure 24. QRT-PCR analysis of IEC-18 cells. Values are relative to control and normalized to
β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values are represented as mean
SEM,
n=4. **, P < 0.01; n.s., not significant.
4.4.8. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression during LTD4
treatment
To determine whether changes in Na-K-ATPase activities are due to altered transcription
of the Na-K-ATPase α1 and β1 subunits protein, Western blot analysis of plasma membrane
(Figure 25) and immunocytochemistry of IEC-18 cells (Figure 26) was performed. Densitometric
analysis of relative protein expression revealed that the level of Na-K-ATPase α1 protein
expression was significantly increased by LTD4 treatment, whereas it remained at control levels
when treated with Cal-C+LTD4 (Figure 25B and 26). Similarly, there was also a significant
increase in Na-K-ATPase β1 subunit protein expression in the plasma membrane (Figures 25A &
C) when treated with LTD4, and this level reverted to normal when treated with Cal-C+LTD4
(Figures 25A & C). Therefore, the expression of Na-K-ATPase α1 and Na-K-ATPase β1
subunits mRNA expression correlated with its protein expression in the plasma membrane. This
shows that LTD4 regulates Na-K-ATPase transcriptionally by increasing mRNA and protein
levels of the α1 and β1 subunits.

83

Figure 25. Western blot analysis of IEC-18 cells when treated with LTD4 and Calphostin-C
(PKC inhibitor). A. Representative western blots of Na-K-ATPase α1, Na-K-ATPase β1 and
Ezrin (internal control). Densitometric quantitation of blots, B. Na-K-ATPase α1 and C. Na-KATPase β1. Values are relative to control and normalized to Ezrin. Values are represented as
mean
SEM, n=4. *, P < 0.05; n.s., not significant.
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Figure 26. Immunocytochemistry of IEC-18 cells when treated with LTD4 and Calphostin
C (PKC inhibitor). A. Representative images of Na-K-ATPase α1(green), and ZO-1(Red),
(20X). B. (Quantification of Na-K-ATPaseα1 (green channel). Values are represented as mean
SEM, n=6. *, P < 0.05; n.s., not significant.
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4.5. DISCUSSION
In the chronically inflamed intestine, Na-glutamine co-transport, mediated by SN2, is
stimulated at the cellular level secondary to the stimulation of Na-K-ATPase. Immuneinflammatory pathway inhibition indicated that these unique changes might mediate through the
leukotriene pathway (S. Singh et al., 2018). Indeed, LTD4 was shown to be elevated in the
chronically inflamed intestinal mucosa. These observations led to the hypothesis that LTD4 may
stimulate Na-K-ATPase thereby facilitating the stimulation of SN2 in crypt cells during chronic
intestinal inflammation. These studies for the first time provided the mechanism of stimulation of
Na-K-ATPase by LTD4 in crypt cells during chronic intestinal inflammation.
To explore the mechanism described above, Rat intestinal epithelial cells (IEC-18) were
used. These cells at 0-day post-confluence phenotypically resemble intestinal crypt cells, and by
day 4 post-confluence mature into villus like cells. Comparable to native crypt cells, IEC-18 cells
at day 0, have SN2 on the BBM but not SGLT1, NHE3 or any other absorptive process (S. Singh
& Sundaram, 2015). Also comparable to crypt cells, IEC-18 cells have Na-K-ATPase, located on
the BLM, to provide the favorable Na gradient for SN2. Thus, these cells are an ideal in vitro
model of intestinal crypt cells.
Alterations in intestinal epithelial cell absorption and secretion are mediated by immune
inflammatory mediators, known to be released in the chronically inflamed intestine (Arthur et al.,
2012; Coon et al., 2010; Coon et al., 2005; Saha et al., 2012). The alteration in absorptive
mechanisms during intestinal inflammation may be due to many immune inflammatory
mediators including prostaglandins, leukotrienes (LTs), chemokines, interleukins, and/or reactive
nitrogen and oxygen species (Sartor & Powell, 1991). Indeed, many of these inflammatory
mediators have been shown to regulate nutrient and electrolyte transport processes during
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chronic intestinal inflammation (Manokas, Fromkes, & Sundaram, 2000; Sundaram & West,
1997; Sundaram, Wisel, & Coon, 2005; Sundaram, Wisel, & Fromkes, 1998b; Sundaram, Wisel,
Rajendren, & West, 1997).
Of the arachidonic acid metabolites known to be increased in the chronically inflamed
intestinal mucosa, there is a wealth of evidence that LTs (LTB4, LTC4, LTD4, and LTE4) are
involved in the alteration of intestinal electrolyte transport in IBD patients (Peskar et al., 1986).
Other studies have shown that the LOX pathway is involved in the stimulation of Na-glutamine
transporter (SN2) and Na-K-ATPase activity in crypt cells in the inflamed intestine of rabbits (S.
Singh et al., 2018). Hence, it was reasonable to postulate that LTD4 mediates the stimulation of
Na-K-ATPase in crypt cells and identify the specific mechanisms by which LTD4 stimulates NaK-ATPase.
This study demonstrated that 1 µM LTD4 for 24 hours is both non-toxic and optimal for
stimulation of Na-K-ATPase in IEC-18 cells. This stimulation of Na-K-ATPase is through LTD4
receptor activation. At the level of the intracellular signaling, receptors CysLT1 and CystLT2
mediate their action through various G-proteins that subsequently alter intracellular Ca2+ or
cAMP (Bouchelouche, Ahnfelt-Ronne, & Thomsen, 1990; Chan et al., 1994; Gronroos, Thodeti,
& Sjolander, 1998; Han, Park, Lee, Lee, & Park, 1999; Thodeti & Sjolander, 2002). This study
demonstrated that LTD4 increased intracellular Ca2+ when exposed to LTD4; thus, when Ca was
chelated, the reversal in the stimulation of Na-K-ATPase was observed; therefore, indicating that
stimulation of Na-K-ATPase is mediated through increased [Ca2+]i.
LTD4 mediated increase of [Ca2+]i, may in-turn activate Ca2+dependent kinases and
downstream signaling (Bouchelouche et al., 1990; Chan et al., 1994; Gronroos et al., 1998; Han
et al., 1999; Thodeti & Sjolander, 2002). Based on the external stimulus, PKC has been shown to
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be involved in the reduction or activation of Na-K-ATPase activity, depending upon species and
tissues studied (Borghini, Geering, Gjinovci, Wollheim, & Pralong, 1994; Feschenko &
Sweadner, 1995). Moreover, the stimulation of various isoforms of PKC can have a differential
effect on Na-K-ATPase. Conventional PKC a and b are associated with decreased activity of
Na-K-ATPase by endocytosis (Chibalin, Pedemonte, et al., 1998; Feraille & Doucet, 2001),
whereas other isoforms of PKC (e and d) have been shown to stimulate Na-K-ATPase activity
through the ERK1/2 pathway (Galuska et al., 2011; Zhong et al., 2005). In the present study, the
PKC pathway was activated by LTD4. When calphostin-c inhibited PKC, LTD4-mediated
stimulation of Na-K-ATPase was attenuated, thus indicating that Ca2+ activated PKC is
responsible for stimulation of Na-K-ATPase. Future studies will need to identify the exact PKC
isoform responsible for the LTD4-mediated stimulation of Na-K-ATPase.
Upon activation of PKC, its modulation of Na-K-ATPase might be due to 1) direct
phosphorylation of Na-K-ATPase a and g subunits, or 2) alteration in transcription factors
associated with various subunits of Na-K-ATPase (Li & Langhans, 2015). In the present study,
LTD4 increased the transcription of the message for the α1 and β1 subunits of Na-K-ATPase and
subsequently the protein levels of these subunits in the plasma membrane. Transcription factors
such specific protein (Sp); Sp1, Sp2, and Sp3 are ubiquitously expressed whereas Sp4 is mainly
confined to neurons and testis (Li & Langhans, 2015). Among these, Sp1 and Sp3 found to
increase the transcription of the α1 and β1subunits by binding to the promoter region of these
subunits (Johar et al., 2012; Kobayashi et al., 1997). Similarly, phosphorylation of transcription
factor CREB induces the increased α1 mRNA level without altering β1subuint mRNA level
(Dagenais et al., 2001). Also, the binding of ZEB1 (AREB6) to the promoter region of the α1
subunit increases the protein level of the α1 subunit in skeletal muscle (Galuska et al., 2011).
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Future studies will decipher the potential transcription factor via which LTD4 may stimulate NaK-ATPase in crypt cells.
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4.6. CONCLUSION
In conclusion, as shown in Figure 27, LTD4-mediated stimulation of Na-K-ATPase in
intestinal crypt cells is due to activation of Ca-mediated PKC, which in-turn activates different
transcription factors regulating expression of α1 and β1 subunits of Na-K-ATPase. Thus, in the
chronically inflamed intestine, LTD4 mediated stimulation of crypt cell Na-K-ATPase which
facilitates the stimulation of the lone nutrient absorptive pathway of these cells, namely SN2, is
via PKC and subsequently enhanced transcription of α1 and β1 subunits of Na-K-ATPase.

Figure 27. Proposed mechanism of LTD4–mediated regulation of Na-K-ATPase in
intestinal epithelial cells. LTD4-Leukotriene-D4, LTR-Leukotriene receptor, PKC-Protein
Kinase C, TF-Transcription Factor.
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4.7. SUPPLEMENTARY FIGURES

Figure 28. Eﬀect of diﬀerent concentration of reagents (drugs) exposure for 24 hours on cell
viability. A. REV5901. B. calphostin-C. C. PMA (Phorbol 12-myristate 13-acetate). D. BAPTAAM. E. Amlodipine. Measurement of cell Viability by MTT assay. Values are relative to 0 µM
and are represented as means ± SEM, n=6. *, P < 0.05 vs 0 µM, **, P < 0.01 vs 0 µM, ***, P <
0.001 vs 0 µM.
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5.1. ABSTRACT
In the mammalian small intestine, villus cells absorb nutrients, electrolytes, and water.
The primary means of absorption of nutrients by villus cells is via Na-dependent nutrient cotransporters located in brush border membrane (BBM) of villus cells. These secondary active cotransport processes require a favorable transcellular Na gradient that is provided by Na-KATPase, an integral basolateral membrane (BLM). Thus, inhibition of villus cell Na-K-ATPase
during chronic intestinal inflammation results in the malabsorption of essential nutrients (e.g.,
amino acids, glucose) via Na-nutrient co-transport pathways. Glutamine is the preferred
metabolite of intestinal epithelial cells. Its villus cell absorption is via Na-glutamine co-transport,
B0AT1. During chronic intestinal inflammation, B0AT1 is inhibited in villus cells, at least
partially secondary to an inhibition of Na-K-ATPase in these cells. Further, specific immune
inflammatory mediators (e.g., PGE2) are elevated in the inflamed intestinal mucosa. But how
PGE2 may mediate the inhibition of Na-K-ATPase in the chronically inflamed intestine is not
known. Therefore, this study aims to determine the effect of PGE2 on Na-K-ATPase in intestinal
epithelial cells and define its mechanism of action. An in vitro model of rat intestinal epithelial
cells (IEC-18 cells line), was used, which resemble villus cells 4-days post-confluence. In IEC18 cells, PGE2 (0.1 μm) significantly reduced Na-K-ATPase activity, as measured by 86Rb+
uptake and Pi release in the plasma membrane, without affecting cell viability. Since PGE2
mediates its action via cAMP-dependent protein kinase A (PKA), cAMP levels were measured
and shown to be increased by PGE2. 8-Bromo-cAMP (cAMP analog) acted similarly to PGE2,
while Rp-cAMP (PKA inhibitor) reversed the PGE2-mediated reduction of Na-K-ATPase
activity. PGE2 caused a significant decrease in mRNA and plasma membrane protein expression
of the Na-K-ATPase α1 and β1 subunits, while Rp-cAMP prevented this inhibition by PGE2.
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These studies demonstrated that the PGE2-mediated reduction of Na-K-ATPase is through the
cAMP-activated PKA pathway in intestinal epithelial cells. The mechanism of inhibition is
secondary to a transcriptional reduction in Na-K-ATPase α1 and β1 subunits. Thus, in an in vitro
model of intestinal inflammation, PGE2 inhibits Na-K-ATPase activity through PKA by
reducing the gene expression of its subunits.
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5.2. INTRODUCTION
Na-K-ATPase is an integral plasma membrane protein specifically present in the
basolateral membrane (BLM) of epithelial cells that transports 3 Na+ out of and 2 K+ into the cell
by utilizing one ATP per each transport cycle. Consequently, pumping Na+ out of the cell, Na-KATPase generates a favorable transcellular Na+ gradient required for nutrient absorption in
mammalian intestinal cells. Thus, Na-K-ATPase drives transporters, specifically Na-dependent
transporters present on the brush border membrane (BBM) in absorptive intestinal villus cells.
Three distinct subunits, alpha (α), beta (β) and gamma (g) subunits constitute a fully
functional Na-K-ATPase enzyme. Of these subunits, α and β subunits are crucial for the proper
functioning of the Na-K-ATPase, whereas the g subunit is not essential for its function (Blanco et
al., 1999; Geering, 1991; Kaplan, 2002). The catalytic α subunit that does the pumping function
can be found in four different isoforms (α1, α2, α3, and α4) and is reported to be expressed in a
tissue-specific manner (Blanco et al., 1999; Kaplan, 2002; Mercer, 1993). However, the
regulatory β subunit facilitates maturation of the α subunit by forming an α/β heterodimer and
transporting this enzyme to the plasma membrane (Geering, 1991). The activity of Na-K-ATPase
can be regulated by various mechanisms: 1) trafficking of pump from cytoplasm to the plasma
membrane (Blanco et al., 1998), 2) transcriptional regulation of subunits (Musch et al., 1982;
Serhan & Kreydiyyeh, 2011), and 3) phosphorylation and dephosphorylation of subunits
(Bertorello & Katz, 1993; Ewart & Klip, 1995; McDonough & Farley, 1993).
Inflammatory bowel disease (IBD) is characterized by the malabsorption of nutrients and
electrolytes, resulting in severe weight loss and malnutrition. Previous studies have shown that
Na-nutrient co-transport pathways in the BBM, namely Na-glucose (SGLT1), Na-alanine
(NAcT), Na-glutamine (B0AT1), Na-bile acid cotransporter (ASBT) and Na-adenosine (DMT1),
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which all depend on the BLM Na-K-ATPase for their optimal activities, are inhibited in villus
cells in a rabbit model of IBD (Ejderhamn et al., 1989; Rachmilewitz et al., 1984; Sundaram &
West, 1997; Sundaram, Wisel, & Fromkes, 1998b). In these cases, it has been reported that there
is decreased Na-K-ATPase activity in villus cells, which implies that Na-K-ATPase might be at
least in part responsible for the improper functioning of those transporters, thus leading to the
malabsorption.
It has been well established that during IBD, various immune inflammatory mediators are
produced endogenously in the intestine (Stadnyk, 2002). These immune inflammatory mediators
work solely or synergistically with one another to affect electrolyte and nutrient transport
pathways (Castro, 1991; Hinterleitner & Powell, 1991; Sartor, 1991). Furthermore, immune
inflammatory mediators such as arachidonic acid metabolites (AAMs) are prominent in the
mucosa of patients with IBD. Specifically, prostaglandin E2 (PGE2) and leukotriene D4 (LTD4)
have been associated with the pathogenesis of IBD and several other diseases including
rheumatoid arthritis, asthma, psoriasis, and multiple sclerosis. PGE2 has been shown to affect
numerous biological activities like water and electrolyte transport in the gut, have vasoactive
effects, and induce smooth muscle contraction (Rachmilewitz et al., 1984). Moreover, the
cyclooxygenase pathway is also responsible for the reduction of B0AT1 and Na-K-ATPase in
villus cells of IBD-induced rabbits (Arthur et al., 2018). However, the molecular mechanisms
responsible for PGE2-mediated reduction of Na-K-ATPase activity have not been determined.
Therefore, this work aims to address the mechanism(s) of PGE2-mediated reduction of Na-KATPase in intestinal epithelial cells.
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5.3. MATERIALS AND METHODS
5.3.1. Reagents
All reagents were purchased from Cayman chemicals (Ann Arbor, Michigan, USA):
Prostaglandin E2 (PGE2, Cat# 14010), AH6809 (Cat# 14050), Rp-cAMP (Cat# 16985), and 8bromo-Cyclic AMP (Cat# 14431) were used in the experiments. All reagents were dissolved in
DMSO to make the stock solutions. Final working concentrations of solutions contained less
than 0.5% DMSO. Toxicity of all the drugs was assessed, and the safe dose was used for further
experiments (Supplementary Figures- Figure 39).
5.3.2. Cell culture
The cells used in experiments were rat intestinal epithelial cells (IEC-18, American Type
Culture Collection), between passages 5 and 20. IEC-18 cells are a non-transformed, polarized
rat epithelial cell line that maintains its integrity and biochemical properties that are similar to in
vivo mammalian intestinal epithelial cells. Cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM), supplemented with 10% (vol/vol) fetal bovine serum, 100 U/l human insulin,
0.25 mM B-hydroxybutyric acid, and 100 units/ml penicillin and streptomycin. These cells were
cultured in a humidified atmosphere of 10% CO2 at 37°C. Cells were fed with fresh DMEM
every other day. When the cells reached 100% confluence, it was considered as 0 day and cells
were grown until 4 days post confluence. All of the experiments were conducted on 4 days post
confluence when they exhibit villus-like features of small intestine.
5.3.3. Cell viability assays
For assessing the cell viability, the MTT (3-(4,5-dimethylthaizol-2-yl)-2,5diphenlytetrazolium bromide) assay was performed. Vybrant MTT cell proliferation kit (cat#V13154) was purchased from Thermofisher Scientific. To perform MTT assay, cells were seeded

98

with an equal number of cells in 96 well plate and cultured, then treated with test chemicals for
desired time. The medium was then removed from the wells and replaced with 100 µl of fresh
medium. After that, 10 µl of 12 mM MTT solution (prepared in PBS) was added and incubated
at 37°C for 2 hours. The whole medium was aspirated and replaced with 100 µl of SDS-HCL
solution to each well and mixed thoroughly. The cells were incubated in SDS-HCL solution
overnight (~12 hrs) at 37°C. Then the solution was again mixed, and absorbance was read on the
spectrophotometer at 570nm. Trypan blue exclusion assay was also performed to measure the
cell viability.
5.3.4. Crude plasma membrane preparation
Crude plasma membrane was prepared from IEC-18 cells following the method of
Havrankova et al.(Havrankova et al., 1978). Cells were well mixed with 2.5-fold 0.001 M
NaHCO3 and homogenized 3 times (10 seconds each) with homogenizer (IKA, Cat# 823707,
T25 S1). These homogenized cells were centrifuged at 600 x g for 30 min. The resultant
supernatant was centrifuged for 30 min at 20,000 x g. The membrane was washed twice with
0.001 M NaHCO3. The final pellet was resuspended in 0.04 M Tris-HCl buffer (pH 7.4)
containing 0.1% BSA. All procedures were carried out at 4oC.
5.3.5. Na-K-ATPase activity assay
Na-K-ATPase activity was measured as Pi liberated in plasma membrane fractions from
IEC-18 cells according to protocol of Forbush (Forbush, 1983). Enzyme-specific activity was
expressed as nanomoles of Pi released per milligram protein per minute.
5.3.6. RNA isolation and qRT-PCR
RNA was isolated from different experimental groups by using RNeasy mini kit obtained
from Qiagen. Real-time quantitative PCR (qRT-PCR) was performed using isolated total RNA
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by a two-step method. First, total RNA was used to synthesize cDNA using SuperScript III kit
(Invitrogen, Life Technologies). Second, newly synthesized cDNA was used as template to
perform real-time PCR using TaqMan Universal PCR master mix from Applied Biosystems
(Foster city, CA) according to manufacturer’s protocol. Rat specific Na-K-ATPase α1- and β1specific primers and probe were used for the qRT-PCR studies. Rat specific β-actin primer and
probe was used as a housekeeping gene to normalize the expression of samples.
5.3.7. 86Rb+ uptake for Na-K-ATPase activity
For uptake studies, IEC-18 cells were grown on transwell inserts (Corning Transwell #
29442, insert size 24 mm, pore size 0.4 µ) in 24 well plates. IEC-18 cells were plated with equal
number of cells. Uptake studies for Na-K-ATPase were done using radioactive Rubidium (86Rb+,
PerkinElmer). Cells were incubated for 1 hr in serum free DMEM (SFM). The cells were
subsequently washed with SFM and incubated for 10 min at 37°C in SFM containing 20 μM
monensin on both sides of the membrane. Then cells were washed with SFM. Na-K-ATPase
uptake studies were then performed by incubating cells for 15 min with reaction mixture [SFM
and 86Rb+ (~1 μCi/well)] on the basolateral side of the membrane in presence and absence of
ouabain (1 mM). The reaction was stopped by addition of ice-cold MgCl2, subsequently washed
three times with MgCl2, and the cells were lysed with 800 μl of 1N NaOH and incubation for 30
min at 70°C, which was then mixed with 5 ml of Ecoscint A (National diagnostics). The vials
were kept in darkness overnight and radioactivity retained by the cells was determined in a
Beckman Coulter 6500 scintillation counter.
5.3.8. cAMP measurement
Calcium measurement was performed using the cAMP Direct immunoassay kit (Abcam,
cat# ab65355). Cells were seeded with an equal number of cells in 35 cm2 dish and cultured until
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4-day post confluent, then treated with test chemicals for desired time. The medium was
aspirated followed by addition of 282 μl of 0.1 M HCl. The suspension was homogenized by
pipetting up and down several times. Then the suspension was centrifuged for 10 minutes at
14,000 rpm. The resultant supernatant collected was used for further experiments. Next the
sample was diluted and mixed with acetylating reagents. After that, the samples were loaded in
96 well plates and incubated with cAMP antibody for an hour; cAMP-HRP was added to each
well and incubated for another hour and washed 3 times with wash buffer. Subsequently, HRP
developer was added and incubated for 1 hr. The reaction was stopped by 1M HCl and the color
developed was read at OD450nm using a plate reader (Spectramax i3x, Molecular Devices).
5.3.9. Western blot analysis
Western blot analysis was performed on plasma membrane fractions prepared from
different samples as described above. Equal amounts of protein (10 μg) were denatured in
sample buffer (10 mM Tris-HCl pH 7, 12% glycerol, 2% SDS, 0.01% bromophenol blue, and
freshly added 1 mM Dithiothreitol) and separated by electrophoresis on a 8% polyacrylamide
gel. Proteins on the gel were transferred to a polyvinylidene fluoride membrane which was
blocked with 5% milk or BSA in TBS (20 mM Tris pH 7.5, 150 mM NaCl) with 0.1% Tween-20
and then incubated with primary antibody against Na-K-ATPase α1 (Millipore, cat# 05-369) or
Na-K-ATPase β1 (Abcam, cat# ab2873) overnight at 4°C. Membranes were washed three times
each with TBS and TBST, followed by incubation with secondary antibody for 1 hr. Membranes
were washed again three times each with TBS and TBST. ECL western blotting detection
reagent (GE healthcare Bio-Sciences, Piscataway, NJ) was used to detect the immobilized
protein. The chemiluminescence was detected using FluorChem instrument (Alpha Innotech, San
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Leandro, CA) and analyzed with its software. Ezrin (Abcam, cat#ab4069) antibody was used to
normalize the expression levels of proteins in plasma membrane fractions.
5.3.10. Immunocytochemistry (ICC) staining
IEC-18 cells were grown on coverslip to 4-day post confluence. Cells were treated with
PGE2 or Rp-cAMP and as mentioned before. Following the treatment for 24 hours, cells were
fixed with 100% methanol (chilled at -20°C) at room temperature for 5 min. After cells were
permeabilized with PBST (PBS + 0.5% Tween 20) for 10 min, cells were blocked with 3% BSA
in PBST for 30 min. Then the cells were incubated for an hour at room temperature with primary
antibodies ZO-1 (Anti-Rabbit; Invitrogen cat# 40-2200), and Na-K-ATPase (Anti-mouse;
Millipore cat# 05-369). Alexa Fluor secondary antibodies (Invitrogen) were added, and the cells
were incubated at room temperature for an hour. Cells were mounted with DAPI-containing
mounting medium (Abcam) and sealed with nail polish to prevent cells from drying. An EVOS
microscope (Invitrogen) was used to capture images and ImageJ software was used for analysis.
5.3.11. Protein determination
Total protein was measured by Lowry method using the DC Protein Assay Kit (Bio-Rad,
Hercules, CA). Different concentrations of BSA were used as standards. Samples were diluted to
200 µl with water. The diluted sample was mixed with 250 µl of DC Protein Assay reagent A
(cat# 500-0113) and incubated for 2 minutes. Subsequently, the sample was incubated for
another 15 minutes after the addition of 2 ml DC Protein Assay reagent B (cat# 500-0114).
Finally, the sample was read at OD750nm using a spectrophotometer.
5.3.12. Statistical analysis
All groups presented have at least n=4 per group, repeated with a different passage. The
values are presented as mean ± SEM, and p-values of <0.05 were taken to indicate statistical
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significance. All of the data were analyzed using t-test, one-way or two-way analysis of variance
(ANOVA) using Graphpad Prism software (San Diego, CA).
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5.4. RESULTS
5.4.1. Effect of PGE2 on Na-K-ATPase in IEC-18 cells
IEC-18 cells were treated with various concentrations of PGE2 for 24 hours (two
treatments 12 hours apart), and the activity of Na-K-ATPase was measured by 86Rb+ uptake.
The lowest dose of PGE2 at which Na-K-ATPase activity was significantly diminished was at
0.1 µm of PGE2 (792±53.2 picomole/mg protein/min) compared to control (1656±95.6) (Figure
29A). The reduction of Na-K-ATPase activity in the plasma membrane by 0.1 µm of PGE2 was
further corroborated by the Na-K-ATPase inorganic phosphate (Pi) release assay (Control18.9±1.64, PGE2, 1 µm-9.36±1.22 nanomole/mg protein/min; Figure 29B).

Figure 29. Eﬀect of PGE2 exposure for 24 hours on Na-K-ATPase activity in IEC-18 cells.
A. Measurement of Na-K-ATPase activity by 86Rb+ uptake (n=6). B. Measurement of Na-KATPase activity by Pi release in plasma membrane preparations (n=4). Values are represented as
means ± SEM. **, P < 0.01 and ***, P<0.001 vs 0 µM or control.
5.4.2. Effect of PGE2 on cell viability
To ensure that a given dose of PGE2 did not aﬀect the viability of IEC-18 cells, MTT and
trypan blue assays were performed. Cell viability was not signiﬁcantly altered with 0.25 µm or
less concentration of PGE2 (Figure 30A). However, there was decreased cell viability in IEC-18
cells with 1 µm or higher concentration of PGE2. |erefore, the concentration we used for our
104

experiments (0.1 µm) did not cause any cell death, which was also validated with the trypan blue
exclusion assay (Figure 30B).

Figure 30. Eﬀect of PGE2 exposure for 24 hours on cell viability. A. Measurement of cell
viability by MTT assay. B. Measurement of cell viability by trypan blue assay. Values are
represented as means ± SEM, n=6. *, P < 0.05, **, P < 0.01 vs 0 µM.
5.4.3. Prostaglandin receptor antagonist blocked PGE2 effect on Na-K-ATPase
The PGE2 receptor antagonist AH6809 was used to determine if the PGE2 effect is specifically
mediated through its receptor in IEC-18 cells. AH6809 is an EP and DP receptor antagonist which blocks
EP1, EP2, EP3, EP4 and DP1 receptors present in cells (Abramovitz et al., 2000). Previous studies from
our laboratory have shown that EP2 and EP4 receptors are present in IEC-18 cells (data not shown). In
this study, IEC-18 cells were pretreated with 5 µM of AH6809 for an hour followed by PGE2 treatment
for 24 hours (two treatments 12 hours apart). As shown in Figure 31, PGE2 significantly inhibited NaK-ATPase, however, pretreatment with AH6089 followed by PGE2 treatment prevented the inhibition
produced by PGE2 (Control-1690±111.1, PGE2-792±81.1, AH6089-1645±115, AH6089+PGE2-

1528±85.4 picomole/mg protein/min). This indicates that the inhibitory effect of PGE2 is mediated
through its receptors EP2 and/or EP4 in IEC-18 cells.
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Figure 31. Eﬀect of PGE2 receptor inhibitor AH6809 (5 µM) on Na-K-ATPase activity in
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as
means ± SEM, n=6. ***, P < 0.001; n.s., not significant.
5.4.4. Effect of PGE2 on intracellular cAMP
In many systems, PGE2 is known to mediate its action via cAMP. This second messenger
is involved in various physiological and pathophysiological processes (Rahman, Buck, & Levin,
2013). Thus, measurement of cAMP was conducted. PGE2 treatment increased the cAMP levels
in IEC-18 cells as shown in Figure 32. cAMP increased 2.4-fold (Control-11.4±2.3, PGE227.09±3.1 picomole/mg protein) within 2 minutes and peaked at 10 minutes (4.3-fold, Control10.1±0.5, PGE2-43.2±3.3 picomole/mg protein) with PGE2. Levels reduced gradually at later
time points (30 minutes, 3.3-fold; Control-11.4±2.9, PGE2-37.7±2.4, 60 minutes, 1.9-fold;
Control-12.9±2.2, PGE2-25±2.8, 180 minutes, 1.8-fold; Control-12.5±4,6, PGE2-22.3±0.6
picomole/mg protein) but were still significantly higher than control. Thus, these data indicate
that PGE2 increased cAMP levels in IEC-18.
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Figure 32. Level of cAMP at diﬀerent time points during PGE2 treatment. Measurement of
cAMP by cAMP Elisa kit. Values are represented as means ± SEM, n=8. *, P< 0.05, **, P< 0.01
and ***, P<0.001 vs Control. Control did not change significantly at different time points.
5.4.5. Effect of an analogue of cAMP on Na-K-ATPase activity in IEC-18 cells
To know whether increased cAMP is responsible for the reduction of Na-K-ATPase, we
used an analog of cAMP: 8-Bromo-cAMP. IEC-18 cells were treated with 0.1 µM 8-BromocAMP for 24 hours (two treatments 12 hours apart) followed by 86Rb+ uptake. The Na-KATPase activity was found to be diminished with 8-bromo-cAMP treatment comparable to PGE2
(Figure 33, Control-1665±108.4, PGE2-780±79.6, 8-Bromo-cAMP-779.8±60.5 picomole/mg
protein/min).
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Figure 33. Eﬀect of cAMP analogue 8-Bromo-cAMP (0.1 µm) on Na-K-ATPase activity in
IEC-18 cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as
means ± SEM, n=6. ***, P < 0.001 vs Control.
5.4.6. Effect of PKA pathway inhibition on Na-K-ATPase activity in IEC-18 cells
It has been demonstrated that cAMP mediates its effects via protein kinase A (PKA) and
subsequent phosphorylation of many proteins (Walsh & Van Patten, 1994). To see whether PKA
plays an active role in the regulation of Na-K-ATPase by PGE2, cells were pretreated with 10
µM of the PKA inhibitor Rp-cAMP for an hour. After pretreatment, cells were treated with
PGE2 for 24 hours (two treatments 12 hours apart) and cellular uptakes for 86Rb+ were
performed. Pretreatment with Rp-cAMP prevented the PGE2-mediated reduction of Na-KATPase (Control-1592±100.9, PGE2-746±75.3, Rp-cAMP-1596±67.3, Rp-cAMP+PGE2-1455±
113.5 picomole/mg protein/min; Figure 34).
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Figure 34. Eﬀect of PKA inhibitor Rp-cAMP (10 µM) on Na-K-ATPase activity in IEC-18
cells. Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as means ±
SEM, n=6. ***, P < 0.001; n.s., not significant.
5.4.7. Na-K-ATPase α1 and Na-K-ATPase β1 subunit mRNA abundance after PGE2
treatment
Gene and protein expression levels of Na-K-ATPase subunits, specifically α and β, are
correlated with its functional activity. While the α subunit is accountable for Na-K-ATPase
pumping activity, the β subunit does not contribute any pumping activity directly but instead
supports α subunit by proper folding and transporting α subunit from the cytoplasm to the plasma
membrane. Therefore, to determine whether changes in Na-K-ATPase activity mediated by
PGE2 are transcriptionally regulated, we performed qRT-PCR analysis. Na-K-ATPase α1
subunit mRNA was significantly decreased when exposed to PGE2, while Rp-cAMP
pretreatment prevented the reduction of Na-K-ATPase α1 subunit (Figure 35A, control-1.00X,
PGE2-0.65X±0.04, Rp-cAMP-0.88X±0.13, PGE2+Rp-cAMP-0.93X±0.09). Similarly, there was
a decrease in Na-K-ATPase β1subunit level when treated with PGE2, but the reduction was
partially abolished when pretreated with Rp-cAMP (Figure 35B, control-1.00X, PGE20.55X±0.06, Rp-cAMP-1.01X±0.16, PGE2+Rp-cAMP-0.85X±0.05). These data indicate that
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Na-K-ATPase α1 and β1 subunits were transcriptionally downregulated when treated with
PGE2. Additionally, the PGE2-mediated decrease in Na-K-ATPase α1 and β1 subunit mRNA
abundance was prevented with Rp-cAMP+ PGE2, indicating that the PKA pathway is
responsible for PGE2-mediated regulation of Na-K-ATPase.

Figure 35. qRT-PCR analysis of IEC-18 cells. Values are relative to control and normalized to
β-actin. A. Na-K-ATPase α1. B. Na-K-ATPase β1. Values are represented as mean
SEM,
n=4. *, P < 0.05, **, P < 0.01; n.s., not significant.
5.4.8. Na-K-ATPase α1 and Na-K-ATPase β1 subunit protein expression after PGE2
treatment
Protein levels of Na-K-ATPase α1 and Na-K-ATPase β1 subunits were determined by
performing immunocytochemistry of cell monolayers and Western blots analysis on plasma
membrane fractions for all experimental conditions. Immunocytochemistry (Figure 36) and
Western blot analysis (Figure 37) showed that relative levels of Na-K-ATPase α1 protein
expression were significantly lowered after PGE2 treatment, whereas this reduction was blocked
when treated with Rp-cAMP+PGE2 (Figure 37A and B, control-1.00, PGE2-0.56±0.26, RpcAMP-1.02±0.19, PGE2+Rp-cAMP-0.93±0.21). Similarly, there was also a significant decrease
in Na-K-ATPase β1 subunit protein expression in plasma membrane fractions when treated with
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PGE2, and this was reversed when treated with Rp-cAMP+ PGE2 (Figure 37A and C, control1.00, PGE2-0.73±0.1, Rp-cAMP-1.06±0.1, PGE2+Rp-cAMP-1.04±0.08). Therefore, the
expression of Na-K-ATPase α1 and β1 subunits mRNA correlated with its protein expression in
plasma membrane fractions. These data indicate that PGE2 regulates Na-K-ATPase
transcriptionally through the cAMP-activated PKA pathway.

Figure 36. Immunocytochemistry of IEC-18 cells treated with PGE2 and Rp-cAMP (PKA
inhibitor). A. Representative images of Na-K-ATPase α1(green), and ZO-1(red), (20X). B.
Quantification of Na-K-ATPase α1 fluorescence. Values are represented as mean
SEM, n=6.
**, P < 0.01 vs Control.
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Figure 37. Western blot analysis of IEC-18 cells treated with PGE2 and Rp-cAMP (PKA
inhibitor). A. Representative western blots of Na-K-ATPase α1, Na-K-ATPase β1 and Ezrin
(internal control). Densitometric quantitation of blots, B. Na-K-ATPase α1 and C. Na-K-ATPase
β1. Values are relative to control and normalized to Ezrin. Values are represented as mean
SEM, n=4. *, P < 0.05, **, P < 0.01; n.s., not significant.
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5.5. DISCUSSION
Prostaglandins play an essential role in maintaining normal physiological processes such
as intestinal secretion, motility, mucosal protection (Mohajer & Ma, 2000). However, they have
also been seen to be increased in the mucosa during chronic enteritis (Ligumsky et al., 1981;
Sharon, Ligumsky, Rachmilewitz, & Zor, 1978). PGE2 has been extensively studied in the
various process such as apoptosis (Huang et al., 2009), and inflammatory processes (Mohajer &
Ma, 2000). Regarding intestinal absorption, PGE2 has been shown to decrease active sodium and
chloride absorption and increase chloride secretion in in vitro studies (Ligumsky et al., 1981;
Sharon et al., 1978). PGE2 has also been involved in the regulation of intestinal epithelial
transporters including Na-glucose (SGLT1) (Hyun, Arai, Onaga, & Kato, 1997; Talukder et al.,
2014), Na/H exchanger (Hodeify & Kreydiyyeh, 2007; Moeser, Nighot, Ryan, Wooten, &
Blikslager, 2006), Na-K-ATPase (Markossian & Kreydiyyeh, 2005) and Cl-/HCO3- (Fujii et al.,
2016). Moreover, our laboratory has also shown that the cyclooxygenase pathway, which
produces prostaglandins, has been involved in the reduction of Na-glutamine uptake (B0AT1)
and Na-K-ATPase activity in villus cells in the inflamed intestine of rabbits (Arthur et al., 2012).
Given this background, it is evident that PGE2 plays a crucial role in transporters involved in
intestinal epithelial cell absorptive pathways, perhaps including Na-K-ATPase during chronic
enteritis. However, the mechanism of regulation of Na-K-ATPase by PGE2 in intestinal
epithelial cells during chronic intestinal inflammation is not known.
In the present study, we demonstrated the mechanisms of regulation of Na-K-ATPase by
the inflammatory mediator PGE2 which in turn regulates several secondary active Na-dependent
nutrient and electrolyte transporters. This work revealed that PGE2 reduces Na-K-ATPase
activity through the PKA-mediated pathway in rat intestinal epithelial cells (IEC-18 cells), which
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physiologically behave like absorptive villus cells when grown four days post-confluent (Saha et
al., 2015).
PGE2 is a well-known regulator of Na-K-ATPase activity in numerous tissue types. A
PGE2-mediated inhibitory effect has been seen in various organs including heart (Skayian &
Kreydiyyeh, 2006), liver (Kreydiyyeh, Riman, Serhan, & Kassardjian, 2007; Seven, Turkozkan,
& Cimen, 2005), and kidney (Cimen, Turkozkan, Seven, Unlu, & Karasu, 2004). Similar to other
findings, our data also demonstrates that 0.1 µM of PGE2 for 24 hours is optimal for reduction of
Na-K-ATPase in IEC-18 cells. Our qRT-PCR data showed that PGE2 transcriptionally reduces
Na-K-ATPase a1 and b1, which led to a decrease in plasma membrane protein expression of
both subunits as demonstrated by western blot analysis.
Previously, our laboratory has shown that IEC-18 cells have PGE2 receptors (EP1, EP2,
EP3, and EP4). The specific inhibitor AH6809 is an EP and DP receptor antagonist and inhibits
these receptors with equal affinity (Abramovitz et al., 2000). When IEC-18 cells were pretreated
with AH6809, the reduction of Na-K-ATPase due to PGE2 treatment was prevented. These data
demonstrate that the decrease of Na-K-ATPase activity is mediated through PGE2 receptors.
These receptors mediate their action through secondary messengers such as Ca2+ or cAMP
(Funk et al., 1993; Woodward, Pepperl, Burkey, & Regan, 1995). We observed that PGE2
increases the intracellular cAMP levels. Therefore, to demonstrate the role of cAMP in the
reduction of Na-K-ATPase, we treated cells with a cAMP analog (8-Bromo-cAMP). There was a
similar effect produced by 8-Bromo-cAMP comparable to PGE2.
PGE2 has been shown to activate signaling pathways through PKA or PKC, downstream
of the second messenger cAMP or Ca2+ in various cell types (Sachs, Villarreal, Cunha, Parada,
& Ferreira, 2009; Sawasdikosol, Pyarajan, Alzabin, Matejovic, & Burakoff, 2007). PKA has
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been shown to have differential regulation (activation, inhibition, or no effect) of Na-K-ATPase
based on the tissue types. The discrepancy in the regulation of Na-K-ATPase by PKA might be
due to phosphorylation of different isoforms of Na-K-ATPase subunits (Blanco et al., 1998).
Oliveira et al. reported that short-term treatment of PGE2 has a PKA-mediated inhibitory effect
on Na-K-ATPase hippocampal tissue likely due to phosphorylation of the Ser943 residue of the
α subunit (Oliveira et al., 2009). On the other hand, cAMP-mediated PKA has also been shown
to regulate Na-K-ATPase transcriptionally. Dagenais et al. reported that activation of PKA by a
cAMP analog subsequently phosphorylates transcription factor CREB and eventually increased
the synthesis of mRNA of the a1 subunit but not the b1subunit after 8 hours treatment in isolated
rat alveolar epithelial cells (Dagenais et al., 2001). However, there was no significant change in
a1 mRNA level after 24 hours of treatment. Additionally, three prostaglandin response elements
(PGRE) have been identified in the b1subunit, which in response to PGE1 (4 hours treatment)
increased the transcription of the b1subunit by activating transcription factors CRE and CREB
(Matlhagela et al., 2005; Matlhagela & Taub, 2006a, 2006b). Contrary to this finding, in our
study, we found that a cAMP-mediated PKA is responsible for inhibition of Na-K-ATPase. The
discrepancy in the results may be due to the different tissues of origin that we used, the
concentration of the PGE2, and/or the exposure time. Another possible reason for this
discrepancy might be the observed effect might be an early response.
However, in a study by Mony et.al, in the hypoxic condition in cancer, transcription
factors hypoxia inducing factor (HIF-1a) and Smad3 bind to the b1 subunit and likely repress
the expression of beta-subunit (Mony et al., 2013). Therefore, the prolonged treatment with
PGE2 might result in transcription repression of b1 subunit by transcription factors like (HIF-1a)
and Smad3.
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5.6. CONCLUSION
The current study indicates that the mechanism by which PGE2 reduces Na-K-ATPase
activity is via the cAMP-mediated PKA pathway, as shown in Figure 38. The mechanism
involves binding of PGE2 to prostaglandin receptors, leading to subsequent activation of the
PKA pathway through increased intracellular cAMP which eventually leads to a decrease in NaK-ATPase activity. The reduction in activity is most likely due to transcriptional repression of
genes encoding various subunits of Na-K-ATPase.

Figure 38. Proposed mechanism of PGE2-mediated regulation of Na-K-ATPase in intestinal
epithelial cells. PGE2-Prostaglandin-E2, EP-Prostaglandin receptor, PKA-Protein Kinase A, TFTranscription Factor.

116

5.7. SUPPLEMENTARY FIGURES

Figure 39. Eﬀect of diﬀerent concentration of reagents (drugs) exposure for 24 hours on cell
viability. A. AH6809. B. Rp-cAMP. C. 8-Bromo-cAMP. Measurement of cell Viability by MTT
assay. Values are relative to 0 µM and are represented as means ± SEM, n=6. *, P < 0.05 vs 0
µM.
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CHAPTER 6: DISCUSSION AND FUTURE DIRECTIONS
6.1. DISCUSSION
The incidence of IBD has been seen to be increasing in the Western world since the
1950s (Lakatos, 2006). Various factors contribute to the pathogenesis of IBD including genetic
heterogeneity, intestinal microbiome, and several environmental factors, thus generating
complexity in the prognosis of the disease (K. L. Wallace, Zheng, Kanazawa, & Shih, 2014).
Individuals suffering from IBD, and specifically with Crohn’s disease, are likely to have
nutritional deficiency because of chronic diarrhea leading to malabsorption of electrolytes and
nutrients (Massironi et al., 2013). Additionally, increased energy expenditure and decreased
nutrient uptake during IBD are known to further worsen the disease condition. Among various
factors that cause diarrhea in IBD, the effects of inflammation on muscular tone and intestinal
transport remain the prominent ones (Wenzl, 2012). The most common treatment to overcome
chronic inflammation and nutrient loss during diarrhea to date are enteral nutrition or steroid
therapy. However, steroids are the first line of treatment in adults with enteral nutrition as
supportive therapy, whereas enteral nutrition remains the preferred treatment in children
(Massironi et al., 2013). Though steroids improve or put the disease in remission, they have been
reported to have numerous side effects causing additional discomfort to the patients. Therefore, it
becomes crucial to identify the immune components that might interfere with the absorption of
specific nutrients in the intestine so that drugs can be developed against them to replace steroids
for IBD treatment.
A comprehensive understanding of nutrient and electrolyte transport during IBD is of
utmost relevance to developing better treatments of IBD. Over the past two decades, there have
been extensive studies on nutrient transporters in a rabbit model of chronic intestinal
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inflammation resembling IBD (Coon et al., 2010; Saha et al., 2012; Sundaram, Wisel, &
Fromkes, 1998a; Sundaram et al., 1997). A series of studies done in this in vivo rabbit model of
IBD have reported that various nutrient transporters, namely Na-glucose (SGLT1), Na-amino
acid [-alanine (ATB0), -glutamine (B0AT1)], Na-bile acid (ASBT), and Na-adenosine
cotransport are significantly reduced in villus cells (Coon et al., 2010; Saha et al., 2012;
Sundaram et al., 1998a; Sundaram et al., 1997). All these studies indicated that along with
decreased nutrient absorption, there was also a decrease in sodium absorption, since all the above
indicated cotransporters of different nutrients are sodium-dependent. Additionally, in this animal
model of IBD, Na-K-ATPase activity was also significantly decreased in villus cells, indicating
decreased transcellular sodium transport, which may be partially responsible for the decreased
nutrient at the brush border membrane. On the contrary, it has also been reported that in crypt
cells there is increased glutamine absorption mediated by the Na-glutamine cotransporter (SN2)
along with increased Na-K-ATPase activity during chronic enteritis in the rabbit model (Saha et
al., 2012). The discrepancy in glutamine absorption between villus and crypt cells during
inflammation of the intestine might be due to villus atrophy and crypt hypertrophy, and the crypt
cells trying to compensate for the loss of glutamine absorption by the villus cells (Saha et al.,
2012). However, this increased glutamine absorption in crypts did not compensate for the loss of
villus cell glutamine absorption, resulting in a net decrease in glutamine absorption across the
villus-crypt axis.
A net decrease in Na and water absorption in the intestine rather than increased anion
secretion resulting in watery stool, has also been reported by other studies in IBD (Hawker,
McKay, & Turnberg, 1980; Sandle, 2005). The net reduction of Na absorption is likely due to
decreased Na-K-ATPase activity (and expression) observed in IBD samples and IBD models
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(Tables 3, 4, and 5). The outcome of decreased Na-K-ATPase activity may result in an elevation
of intracellular Na level, thus reducing the Na and Na-dependent nutrient absorption capacity of
the enterocytes.
Given this background, it becomes important to understand the intracellular signaling and
molecular mechanisms responsible for the alteration of sodium absorptive processes in the
intestine during IBD. However, in vivo systems do not facilitate effective manipulation and
dissection of specific cellular processes and protein targets due to their physiological complexity.
Therefore, there was a need to develop an in vitro model, which could behave like either crypt or
villus cells under defined culture conditions. To date, the majority of investigations related to
absorptive and inflammatory mechanisms were done in colon cancer cell lines (Caco-2 or T-84),
which do not represent the small intestinal enterocytes well (Table 3). Additionally, the
complexity generated by the effects of oncogenesis on these cell lines makes them less ideal for
studying effects mediated by immune-inflammatory mediators. However, a rat small intestinederived normal intestinal epithelial cell line called IEC-18 has been successfully used as an in
vitro model to study enterocytes at the level of either immature crypt-like cells and mature villuslike cells.
Based on this background, the objective of the current study was to dissect the specific
molecular mechanisms responsible for the modulation of sodium-dependent nutrient transporters
and Na-K-ATPase by specific immune inflammatory mediators in villus and crypt cells. To
accomplish this objective, this study was divided into different sub-projects. The first study was
to characterize the in vitro model (IEC-18) so it could be used as a cell model comparable to both
crypt and villus enterocytes. Once establishing IEC-18 as an appropriate in vitro system to study
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both crypt and villus cells, we then studied the effect of specific immune inflammatory mediators
on Na-K-ATPase activity. Our findings are summarized below.
6.1.1. Maturation of IEC-18 cells
During the maturation of intestinal absorptive cells from crypt to villus, significant
morphological and physiological changes occur. Morphological changes include changes in
membrane composition and surface area, so that physiologically mature cells acquire more
transporters and therefore increased capacity to absorb nutrients. A study of the crypt-villus axis
of piglets has shown that there is upregulation of proteins associated with
glycolysis/gluconeogenesis, fatty acid metabolism, amino acid metabolism, and citrate cycle as
cells mature from crypt to villus (Yang et al., 2016). Additionally, it has been reported that ALP,
aminopeptidase, sucrose, lactase and Na-K-ATPase activities increased along the crypt-villus
axis in jejunum and ileum of neonatal pigs (Fan et al., 2001). Similar to these results, our study
has shown that there is an increase in ALP and SGLT1 activities as IEC-18 cells mature from
crypt-like to villus-like in culture.
6.1.2. Regulation of Na-K-ATPase during intestinal cell maturation
There are contradictory reports in the literature addressing the levels of Na-K-ATPase
activity during the maturation of intestinal epithelial cells (Blostein et al., 1983; Brugnara & de
Franceschi, 1993; Furukawa et al., 1981). The mechanism involved in the reduction of activity
was found to be due to the shedding of Na-K-ATPase into exosomes or due to degradation by
energy-dependent mechanisms (Mairbaurl et al., 2000). Moreover, studies from our lab have
demonstrated that the activity of Na-K-ATPase is elevated in villus cells compared to the crypt
cells (Saha et al., 2012). In these studies, Na-K-ATPase activity varied depending upon the
physiological nutritional demand of the intestinal epithelial cells during the maturation process.
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Supporting this notion, the present study has shown that there is an increase in Na-K-ATPase
activity as IEC-18 cells mature from crypt-like to villus-like.
While intestinal epithelial cells mature from crypt to villus, Na-K-ATPase activity also
increases to support the increasing absorptive capacity of the enterocytes. The results of this
study showed that the increased Na-K-ATPase activity in villus-like cells compared to crypt-like
cells is likely due to the change in the affinity of the transporter rather than an elevated
expression of Na-K-ATPase. Moreover, the differences in affinity are due to changes in
phosphorylation of the α1 subunit of Na-K-ATPase, specifically at serine and tyrosine residues.
6.1.3. Regulation of Na-K-ATPase during induced inflammatory condition (LTD4
treatment) in crypt-like cells
Various inflammatory mediators such as prostaglandins, leukotrienes, chemokines,
interleukins, and/or reactive nitrogen and oxygen species are known to modulate intestinal
nutrient and electrolyte transporters (Sartor & Powell, 1991). The mechanisms of modulation by
these factors are unique to the transporters during chronic intestinal inflammation (Manokas et
al., 2000; Sundaram & West, 1997; Sundaram et al., 2005; Sundaram et al., 1998b; Sundaram et
al., 1997). Previously, our laboratory has shown that the LOX pathway, which produces
leukotrienes, is involved in the stimulation of Na-glutamine transporter (SN2) and Na-K-ATPase
activity in crypt cells in the inflamed intestine of rabbits (S. Singh et al., 2018). In agreement
with this study, the present study also demonstrates that there is increased Na-K-ATPase activity
during LTD4 exposure to crypt-like cells. Subsequently, the LTD4-mediated stimulation of NaK-ATPase in intestinal epithelial cells is due to Ca-mediated activation of the PKC (Figure 40),
which in turn may activate different transcription factors upregulating the expression of the NaK-ATPase a1 and b1 subunits.
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6.1.4. Regulation of Na-K-ATPase during induced inflammatory condition (PGE2
treatment) in villus-like cells
PGE2-mediated inhibitory effect on transporter has been seen in various organs including
the heart (Skayian & Kreydiyyeh, 2006), liver (Kreydiyyeh et al., 2007; Seven et al., 2005), and
kidney (Cimen et al., 2004). Additionally, our laboratory has also shown that the cyclooxygenase
pathway, which produces various prostaglandins, has been involved in the reduction of Naglutamine (B0AT1) and Na-K-ATPase activity in villus cells in the inflamed intestine of rabbits
(Arthur et al., 2018). Similar to these findings, the present study also demonstrates that PGE2
reduces the activity of Na-K-ATPase in villus-like cells in vitro. Moreover, the mechanism of
inhibition of Na-K-ATPase in intestinal epithelial cells is due to cAMP-mediated activation of
the PKA pathway (Figure 40), which in turn may be modulating the transcription factors
downregulating the expression of the Na-K-ATPase a1 and b1 subunits.

Figure 40. Schematic representation of mechanisms of alteration of Na-K-ATPase activity
by inflammatory mediators (LTD4 and PGE2) during intestinal inflammation.
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6.2. FUTURE DIRECTIONS
6.2.1. Regulation of Na-K-ATPase during maturation of intestinal cells
The present study provides the potential regulation of Na-K-ATPase during the
maturation of intestinal cells. While the study is novel, the limitation of this study is that the
model is in vitro, and further studies need to be done ex vivo or in vivo to support the current
findings. For example, we can sequentially isolate cells from the immature crypt base to the
mature villus tips in rabbit or rat intestine and determine if comparable changes occur in vivo as
it pertains to Na-K-ATPase. In addition to investigating the molecular mechanisms involved in
the altered activity of Na-K-ATPase during the maturation process, further studies need to be
done to decipher external cellular factors that bring about these alterations. As was demonstrated,
PGE2 and LTD4 have very different effects on Na-K-ATPase in crypt-like and villus-like states
of IEC-18 cells. Thus, such external mediators may regulate Na-K-ATPase during maturation.
6.2.1.1. Locating the phosphorylation residues involved in modulation of Na-KATPase during maturation
Our data revealed that there is alteration of phosphorylation levels of serine and tyrosine
residues in the Na-K-ATPase α1 subunit during the maturation of intestinal epithelial cells from
crypt to villus. There are several phosphorylation targets in Na-K-ATPase α1, which are known
to modulate the activity of the enzyme depending on the tissue type and experimental conditions
(Beguin et al., 1994; Chibalin et al., 1992). Additionally, we observed in this study that Na-KATPase α1-Ser23 phosphorylation increases as cells mature, along with increases in Na-KATPase activity. Besides Ser23, there are phosphorylation sites at Tyr5 and Ser943 in the α1
subunit that are also known to modulate the activity of Na-K-ATPase (Beguin et al., 1994;
Efendiev et al., 2000). Thus, further studies with point mutations of potential serine and tyrosine
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phosphorylation sites will help to decipher and understand the mechanisms of regulation of NaK-ATPase during maturation.
6.2.1.2. Finding the role of FXYD subunit
There are 12 different members of the FXYD protein family that are known to be
expressed differentially in cells and tissues (J. Y. Cheung et al., 2010). A specific domain at the
N terminus of FXYD is known to interact with Na-K-ATPase thereby regulating the activity of
Na-K-ATPase, whereas the C terminus consists of phosphorylation sites that could be potential
targets of activation by kinases (Dey et al., 2013). In the present study, we did not explore the
role of FXYD in the regulation of Na-K-ATPase. Therefore, future studies should be conducted
to explore the potential role of FXYD in the modulation of Na-K-ATPase activity during the
maturation of intestinal epithelial cells.
6.2.2. Regulation of Na-K-ATPase by inflammatory mediators (LTD4 and PGE2
treatment)
In addition to investigating the mechanism of how inflammatory mediators LTD4 and
PGE2 works in crypt and villus, we also treated crypt cells with PGE2 and villus cells with
LTD4 (Figure 41). We observed that PGE2 and LTD4 did not have any effect on Na-K-ATPase
activities in crypt and villus cells, respectively. However, the question remains on the fact that
the epithelial cells lose their sensitivity to LTD4 treatment and acquire PGE2 sensitivity. To
explore this interesting phenomenon, further studies need to be conducted to investigate the
LTD4 and PGE2 receptor development/transition during the maturation of intestinal epithelial
cells. Changes subsequent to agonist-receptor interaction, specifically at the G protein level is
another possibility which needs to be explored as well.
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Figure 41. Eﬀect of LTD4 and PGE2 exposure for 24 hours on Na-K-ATPase activity in
IEC-18 cells. A. Crypt-like cells (0-day confluence). B. Villus-like cells (4-day confluence).
Measurement of Na-K-ATPase activity by 86Rb+ uptake. Values are represented as means ±
SEM, n=6. **, P < 0.01 Vs Control, ***, P < 0.001 Vs Control.
6.2.2.1. Exploring the role of different PKC isoforms during LTD4-mediated
stimulation of Na-K-ATPase
Based on the external stimulus, PKC has been involved in reduction or activation of NaK-ATPase activity depending upon species and tissues (Borghini et al., 1994; Feschenko &
Sweadner, 1995). Moreover, the stimulation of various isoforms of PKC can have a differential
effect on Na-K-ATPase. Conventional PKC a and b are associated with decrease in activity of
Na-K-ATPase by endocytosis (Chibalin, Pedemonte, et al., 1998; Feraille & Doucet, 2001),
whereas other isoforms of PKC, e and d have been shown to stimulate Na-K-ATPase activity
through the ERK1/2 pathway (Galuska et al., 2011; Zhong et al., 2005). In the present study, we
used calphostin-c, a non-isoform specific PKC inhibitor. Therefore, using specific isoform
inhibitors will further dissect the mechanism of LTD4-mediated stimulation in intestinal
epithelial cells.
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6.2.2.2. Exploring the role of transcriptional factors during LTD4-mediated
stimulation of Na-K-ATPase
We observed the transcriptional activation of the Na-K-ATPase α1 and β1 subunits
during LTD4 treatment in crypt-like cells. Transcription factors such as Sp1 and Sp3 are known
to increase the transcription of the α1 and β1 subunits by binding to the promoter region of these
subunit genes (Johar et al., 2012; Kobayashi et al., 1997). Similarly, phosphorylation of
transcription factor CREB is known to induce the increased α1 mRNA level (Dagenais et al.,
2001). Also, the binding of ZEB1 (AREB6) to the promoter region of the α1 subunit gene
increases the protein level of the α1 subunit in skeletal muscle (Galuska et al., 2011). Therefore,
future studies observing the role of these transcription factors might be helpful in understanding
the transcriptional modulation of LTD4-mediated stimulation of Na-K-ATPase in intestinal
epithelial cells.
6.2.2.3. Exploring the role of transcriptional factors during PGE2-mediated
reduction of Na-K-ATPase
In the present study, we observed the transcriptional repression of the Na-K-ATPase α1
and β1 subunits during PGE2 treatment in villus-like cells. It has been reported that TGF-β2
reduces the mRNA level of the β1 subunit through transcription factors HIF and Smad3 (Mony
et al., 2013). Therefore, these transcription factors might play a potential role in the PGE2mediated reduction of Na-K-ATPase activity and hence need to be studied. However, there is no
report suggesting a potential transcription repressor for the α1 subunit; therefore, further studies
need to be done to explore the involvement of potential transcriptional repressors of the α1
subunit.
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APPENDIX B: ABBREVIATIONS
AA

Arachidonic acid

AAMs

Arachidonic acid metabolites

ADP

Adenosine Diphosphate

ALP

Alkaline phosphatase activity

ANOVA

Analysis of Variance

ASBT

Apical sodium bile acid transporter

ATF

Activating transcription factor

ATK

Arachidonyl Trifluoromethyl Ketone

ATP

Adenosine Triphosphate

B0AT1

System B0 amino acid transporter 1

BBM

Brush border membrane

BLM

Basolateral membrane

BSA

Bovine serum albumin

C-terminal

COOH-terminal

Ca2+

Calcium ion

CaCl2

Calcium chloride

Cal-c

Calphostin-C

cAMP

Cyclic adenosine monophosphate

CD

Crohn’s Disease

cDNA

Complementary Deoxyribonucleic acid

CFTR

Cystic fibrosis transmembrane conductance regulator

cGMP

Cyclic guanosine monophosphate
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Cl-

Chloride ion

COX

Cyclooxygenase

CRE

cAMP response element

CREB

cAMP response element binding protein

CTF

Cardiotonic factor

CysLT

Cysteinyl leukotriene receptors

DMEM

Dulbecco’s modified eagle media

DMSO

Dimethyl sulfoxide

DMT1

Divalent metal transporter 1

ECL

Enhanced chemiluminescence

EGFR

Epidermal growth factor receptor

ERK

Extracellular signal-regulated kinases

GI

Gastrointestinal

GPCR

G-protein-coupled receptors

GPI

Glycosylphosphatidylinositol

GRE

Glucocorticoid response element

H+

Hydrogen ion

HCl

Hydrochloric acid

HCO3-

Bicarbonate ion

HEPES

4-(2-hydroxyethyl-1-piperazineethanesulfonic acid)

HETEs

Hydroxy eicosatetraenoic acids

HIF

Hypoxic inducing factors

HPETEs

Hydroperoxyeicosateraenoic acids
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HRE

Hypoxia response element

HRP

Horse radish peroxide

IBD

Inflammatory Bowel Disease

ICC

Immunocytochemistry

IEC

Intestinal epithelial cells

IFN-g

Interferon gamma

IHC

Immunohistochemistry

IL

Interleukin

IL-1b

Interleukin-1b

IP

Immunoprecipitation

IP3R

Inositol triphosphate receptor

Isc

Short-circuit current

K+

Potassium ion

KCl

Potassium chloride

kDa

Kilo Dalton

Km

Michaelis-Menten constant

LOX

Lipoxygenase

LT

Leukotriene

LTB4

Leukotriene B4

LTC4

Leukotriene C4

LTD4

Leukotriene D4

LTE4

Leukotriene E4

LTR

Leukotriene receptor
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LXA4

Lipoxins A4

LXB4

Lipoxins B4

M

Molar

MAPK

Microtubule associated protein kinase

MgCl2

Magnesium chloride

MgSO4

Magnesium sulphate

mM

Millimolar

MMC

Migrating motor complex

MRE

Mineralocorticoid response element

mRNA

Messenger Ribonucleic acid

MTT

3-(4,5-dimethylthaizol-2-yl)-2,5-diphenlytetrazolium bromide

N-terminal

NH2-terminal

N/A

Not available

Na-K-ATPase

Sodium Potassium Adenosine Triphosphate

Na+

Sodium ion

NaCl

Sodium chloride

NAcT

Sodium alanine co-transporter

NaHCO3

Sodium bicarbonate

NaOH

Sodium hydroxide

NB

Northern blotting

NHE

Na-Hydrogen exchanger

NSAID

Nonsteroidal inflammatory drugs

OD

Optical Density
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OMG

O-Methyl Glucose

PBS

Phosphate buffer saline

PG

Prostaglandin

PGD2

Prostaglandin D2

PGE2

Prostaglandin E2

PGF2

Prostaglandin F2

PGG2

Prostaglandin G2

PGH2

Prostaglandin H2

PGI2

Prostacyclin I2

PGRE

Prostaglandin response element

Pi

Inorganic phosphate

PI3K

Phosphoinositide 3-kinase

PKA

Protein kinase A

PKC

Protein kinase C

PKG

Protein kinase G

PLA2

Phospholipase A2

PLC

Phospholipase C

PMA

Phorbol 12-myristate 13-acetate

PO42-

Phosphate ion

PRE

Progesterone element

PRX

Piroxicam

PTK

Protein tyrosine kinase

PTP

Protein tyrosine phosphatase
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qRT-PCR

Quantitive real time -Polymerase chain reaction

RB+

Rubidium ion

RbCl

Rubidium chloride

ROS

Reactive oxygen species

Rp-cAMP

Rp-Cyclic adenosine monophosphate

SBD

Smad binding domain

SDS

Sodium dodecyl sulphate

SEM

Standard error of mean

Ser

Serine

SFM

Serum free medium

SGLT1

Sodium-Glucose Transporter 1

SN2

System N transporter 2

SO42-

Sulphate ion

Sp

Specificity protein

Src

Sarcoma

STAT

Signal transducer and activator of transcription

TBS

Tris buffer saline

TBST

Tris buffer saline tween20

TF

Transcription Factor

TJ

Tight junction

TNF-a

Tumor necrosis factor-a

TRE

Thyroid response elements

TXA2

Thromboxane A2
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TXB2

Thromboxane B2

Tyr

Tyrosine

UC

Ulcerative colitis

Vmax

Maximum rate of reaction

WB

Western blot

WB-PM

Western blot in plasma membrane

WB-WC

Western blot in Whole cell

ZEB

Zinc finger E-Box Binding Homeobox 1

ZO

Zonula occludens

μM

Micromolar



Up-regulation in in activity and expression

¯

Down regulation in activity and expression

Û

No change
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